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ABSTRACT 
 
In this MSc, novel methodology for the synthesis of xanthones and related 
compounds was discovered. 
 
It was found that treatment of (1,4-dimethoxynaphthalen-2-yl)(2-
hydroxyphenyl)methanone with ceric ammonium nitrate (CAN) resulted in the 
formation of 12a-methoxy-5H-benzo[c]xanthene-5,7(12aH)-dione as the product. The 
structure was confirmed by X-ray crystallography. 
 
Exposure of a related compound (2,5-dimethoxyphenyl)(2-hydroxyphenyl)methanone 
to CAN afforded 2-methoxy-9H-xanthen-9-one as the major product with 4a-
methoxy-2H-xanthene-2,9(4aH)-dione formed as the minor product. This reaction 
sequence has opened a new door for research into xanthone synthesis at the 
University of the Witwatersrand   
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INTRODUCTION 
 
Oxygenated heterocycles play an important role in the design and discovery of new 
physiological/pharmacologically active compounds1. Chemically xanthones (9H-
xanthen-9-ones) are heterocyclic compounds with the dibenzo-γ-pyrone framework 
(1). In nature xanthones, are secondary metabolites that occur in fungi and higher 
plant families such as lichens2. Naturally occurring xanthones with nearly one 
thousand known members, contain different types of substituents in different 
positions, leading to a large variety of pharmacological activities3. 
 
 
Figure 1: The basic skeletal structure of xanthones. 
 
WITS INTEREST IN XANTHONES 
 
In 1988 de Koning and Giles synthesized bikaverin (2), a wine red pigment isolated 
from several species of the fungal genera Fusarium, Gibberella and Mycogone4. It 
held a number of interesting biological activities which included vacuolation5, anti-
protozoal6 and anti-tumour activities7. The core structural feature of bikaverin (2) was 
its xanthone nucleus. Bikaverin (2) was identified by Kjaër and co-workers, along 
with norbikaverin (3) in 19718. 
 
 
Figure 2: The structures of bikaverin (2) and norbikaverin (3). 
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To construct the xanthone nucleus (Scheme 1), de Koning et al.4 first introduced the 
carbonyl bridge via a mild Friedel Crafts reaction using trifluoroacetic anhydride 
(TFAA) with the prepared naphthalene derivative (4) and the aryl acid (5), to give the 
desired product as a single regioisomer (6) in 51% yield. Compound (6) was then 
deprotected using palladium on carbon in the presence of hydrogen under pressure, to 
afford the phenol (7) in 80% yield. The phenol (7) was oxidised using DDQ, which 
surprisingly produced the spiro-compound (8) in 61% yield. The spiro compound (8) 
was hydrolyzed to the desired trione (9) using aqueous trifluoroacetic acid (TFA) in 
94% yield. The trione (9) underwent pyrolytic isomerization to produce the xanthone-
based compound (2) in 93% yield.   
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Scheme 1: (i) TFAA, dry CH2Cl2, rt, 90 h, 51%; (ii) 10% Pd/C, H2, 5 bar, 1 h, 80%; 
(iii) DDQ, dry benzene, rt, 68 h, 61%; (iv) TFA (aq), CH2Cl2, rt, 5 min, 94%;  
(v) 200 °C, 1.1 bar, 1 h, 93%. 
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Since this synthesis, very little exploratory work has been done in investigating the 
mechanism of the DDQ facilitated reaction leading to the formation of the spiro-
compound (8). There was also a need to explore the flexibility of this novel synthesis 
particularly on more electron poor precursors. Due to the diverse biological activity of 
xanthones, it is important to find a versatile synthetic approach that allows for the 
maximum amount of flexibility to afford a range of xanthone ring systems. 
 
This MSc dissertation will be divided into the following sections: Firstly a general 
discussion on the biological activity of xanthones. Only a few examples will be 
selected in this section, as this field is vast. The second section will deal with some of 
the synthetic methods reported in the literature for the assembly of xanthones. These 
will then be followed by a discussion of the results obtained in our laboratories which 
will be discussed in detail. 
 
We will highlight our novel methodology discovered during the course of this MSc 
that led to the formation of xanthones and related compounds. 
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BIOLOGICAL ACTIVITY 
 
The xanthone nucleus comprises of an important class of the oxygenated 
heterocycles9. The growing interest in this class of compounds has been associated 
with its diverse pharmacological properties. Pharmacological investigations of 
xanthones date back to 1968, when Bhattacharya reported the diuretic and cardiotonic 
actions of the natural glycoside mangeferin (10)10. 
 
 
Figure 3: The structure of mangeferin (10). 
 
Discussed below are a few xanthones that exhibit activity against cancer, HIV-AIDS 
and malaria. 
 
ANTI-CANCER XANTHONES 
 
Among the myriad of biological activities described for xanthones, the in vitro growth 
inhibitory activity on tumor cell lines appeared to be quite remarkable, since they are 
biologically active on a wide range of tumor cell lines3. Apart from the anti-tumor 
activity, some xanthones have been described for their anti-mutagenic effects11 and 
for their cancer chemo-preventative effects, acting as inhibitors of tumor promoters in 
vitro12 and in vivo13. 
 
PSOROSPERMIN 
Psorospermin (11) is a naturally occurring compound, containing an angular 
furanoxanthone as well as a reactive epoxide moiety. Psorospermin (11) was first 
isolated by Kupchan and co-workers, from the dried roots of a woody plant ,of 
tropical Africa known as Psorospermum febrifugum14. They managed to elucidate the 
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structure but could not assign the absolute stereochemistry of the dihydrofuran ring or 
the epoxide moiety. The ethanolic extract of Psorospermum febrifugum was found to 
exhibit significant activity in vivo against P-388 lymphocytic leukemia in mice and in 
vitro against a cell culture derived from a human epidermoid carcinoma of the 
nasopharynx (9KB)15. Kupchan and co-workers demonstrated that this activity was 
due to psorospermin (11) which exhibited activity against P-388 lymphocytic 
leukemia in doses ranging from 0.1 mg.kg-1 to 8 mg.kg-1 and showed some 
cytotoxicity against the KB cell culture (ED50 = 10-1 μg.mg-1)14. 
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(11)  
Figure 4: The structure of psorospermin (11). 
 
Years later, Cassady et al.16 were able to assign the absolute stereochemistry of 
psorospermin (11) as being 2’R, 3’R, using 1H NMR spectroscopy and X-Ray 
crystallographic studies. After elucidating the absolute stereochemistry, Cassady et 
al.16 synthesized three derivatives (12-14) but their activity was significantly less than 
psorospermin, therefore establishing the importance of the configuration and 
functionality of the epoxydihydrofuran moiety to activity in vivo. 
 
 
Figure 5: The structures of psorospermin derivatives (12-14). 
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Cassady and co-workers17 also attempted a total synthesis of psorospermin (11) but 
only managed to synthesize methyl-(±)-(2’R,3’S)-psorospermin (15) but this synthesis 
did, however, lay the foundations for future work. More recently Schwaebe and co-
workers18 used the similar “zipper type” reaction to afford the first total synthesis of 
psorospermin (11) in 13 steps with an overall yield of 1.7%. 
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Figure 6: The structure of methyl-(±)-(2’R, 3’S)-psorospermin (15). 
 
The xanthone structure plays a pivotal role in the cancer activity of psorospermin 
(11). Psorspermin (11) is believed to be a topoisomerase II poison. Topoisomerase II 
is an enzyme that plays several key roles in DNA metabolism and chromosome 
structure19. Psorospermin (11) intercalates into the DNA helix, and the epoxide ring 
undergoes nucleophilic attack by N7 of guanine (16) creating ion (17) that is cationic 
in nature and therefore may dipurinate inside cells20 (Scheme 2). Psorospermin (11) 
intercalates parallel to the helical axis and it shows poor reactivity and poor selectivity 
towards duplex DNA but in the presence of topoisomerase II, alkylation reactivity of 
psorospermin (11) increases significantly20.  
 
Hurley et al.21 proved that the carbonyl and ether linkage of the xanthone backbone 
play a vital role in the reactivity as they interact with 2-amino groups from the 
topoisomerase II-DNA complex ensuring that the epoxide is in close proximity to the 
N7 of guanine (16). Psorospermin (11) irreversibly binds to the topoisomerase-DNA 
complex thus having a clinical advantage associated with more potent cytotoxic 
effects towards cancer cells22. 
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Scheme 2 
 
GAMBOGIN AND GAMBOGIC ACID 
Gambogin (18) and gambogic acid (19) have an unusual molecular architecture. They 
contain caged motifs attached to a xanthone scaffold. In 1996, Tada and co-workers 
isolated gambogin (18) and gambogic acid (19) from the gamboges resin of Garcinia 
hamburyi23. Gambogin and gambogic acid were tested against the cancer cell lines 
HeLa and HEL (Human Embryonic Lung Fibroblasts). Both gambogin (18) and 
gambogic acid (19) showed good cytotoxicity of 6.25 μg.ml-1 and 12 μg.ml-1 
respectively against the respective cell lines23. 
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Figure 7: The structures of gambogin (18) and gambogic acid (19). 
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By 2005 Nicoloau et al.24 had reported the biomimetic total synthesis of gambogin 
(18), via a site selective Claisen/Diels Alder/Claisen rearrangement. Gambogin (18), 
along with derivatives (20) and (21), were tested against the human epidermoid 
cancer cell line KB-31 with good success, exhibiting high cytotoxicity. 
 
 
Figure 8: The structures of gambogin derivatives (20-21). 
 
The anti-cancer activity of gambogin (18) and gambogic acid (19) has been identified 
as proceeding by apoptosis induction25. Apoptosis, also known as programmed cell 
death, plays critical roles in normal cell development as well as elimination of 
excessive or dysfunctional cells26. Caspases, especially caspase 3, also known as 
executioner proteins, are pivotal in apoptosis because it cleaves multi-protein 
substrates in cells, leading to irreversible cell death27. Inadequate apoptosis such as, 
defects in the molecular machinery to activate the caspase cascade, is one of the 
hallmarks of cancer cells28. Cai and co-workers found that the 9-10 carbon-carbon 
double bond of the α,β-unsaturated ketone, relating to the carbonyl bridge of the 
xanthone backbone, in gambogin (18) and gambogic acid (19), was found to be 
critical in its apoptosis activity29. If the double bond is saturated, gambogin (18) and 
gambogic acid (19) are devoid of apoptosis inducing and anti-proliferative activity29. 
Thus the xanthone scaffold is vital to the activity of gambogin (18) and gambogic acid 
(19). 
 
α-MANGOSTIN 
Phytochemical studies have shown that the pericarps of mangosteen, Garcinia 
mangostana, contain a variety of secondary metabolites, such as oxygenated and 
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prenylated xanthones30. One of these xanthones is α-mangostin (22), which shows 
considerable activity against many cancer cell lines. 
 
 
Figure 9: The structure of α-mangostin (22). 
 
The total synthesis of α-mangostin (22) was reported by Iikubo et al.31 (Scheme 3). 
They used PPh3/CCl4 and silica to cyclize the benzophenone (23) to α-mangostin (22)  
 
 
Scheme 3: (i) PPh3, CCl4, THF, silica, rt. 
 
Matsumoto and co-workers32 proved that α-mangostin (22) in a dose as low as 10 μM 
induced apoptosis in the human leukemia cell line HL60. Unlike gambogin (18) and 
gambogic acid (19), α-mangostin (22) induced programmed cell death by targeting 
the mitochondria and causing loss in cell membrane potential rather than caspase 
activation33. α-Mangostin (22) was tested against human colon cancer DLD-1 cells 
and showed inhibition at 20 μM by inducing cell cycle arrest via the same pathway34, 
which was detected in the increase in measurement of endonuclease G from the cells 
due to loss of cell membrane potential35.  
 
The anti-cancer activity of α-mangostin (22) can be attributed in part to the number of 
phenolic groups on the molecule and the replacement with a methoxy group 
remarkably reduced the potency to decrease cell membrane potential.33 
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α-Mangostin (22) has shown moderate activity against breast cancer. The risk of 
breast cancer increases with prolonged estrogen exposure36. A strategy to decrease 
estrogen production involves aromatase inhibition. Aromatase is responsible for 
catalyzing the biosynthesis of estrogens from androgens37. α-Mangostin (22) caused 
aromatase inhibition at a moderate concentration of 20 μg.ml-1 38. 
 
The xanthone structure thus plays an important role in the cancer activity of              
α-mangostin (22) as it allows for many sites for the phenolic group substituents on the 
bridged benzene rings on either side of the carbonyl bridge, while still maintaining its 
aromaticity. This allows for intercalation of the xanthone to DNA in cells, as well as 
hydrogen bonding between the carbonyl and ether bridges with amino acid residues in 
enzymes. 
 
ANTI HIV-AIDS XANTHONES 
 
More recently natural xanthones have shown activity against the human 
immunodeficiency virus (HIV). Apart from their activity against the virus directly, 
many xanthones have secondary therapeutic properties against fungal infections in 
immune-compromised patients due, to acquired immunodeficiency syndrome 
(AIDS)39. 
 
SWERTIFRANCHESIDE 
Swertifrancheside (24), a complex xanthone containing compound, was first isolated 
by Cordell and co-workers in 1994, from Swertia franchetiana40. Swertifrancheside 
(24) is a flavone xanthone glycoside and is a moderately potent inhibitor of HIV 
reverse transcriptase. 
 
Over the past 25 years, substantial progress has been made in defining strategies for 
the treatment of HIV infection, the cause of AIDS41. Since reverse transcriptase is 
required early in proviral synthesis42, inhibition of reverse transcriptase-catalyzed 
polymerization of DNA from viral RNA, inhibits virus replication. Reverse 
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transcriptases may be viral specific and are thus considered viable chemotherapeutic 
targets. 
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Figure 10: The structure of swertifrancheside (24). 
 
Swertifrancheside (24) showed inhibitory activity of 99.8% at 200 μg.ml-1 (ED50=  
30.9 μg.ml-1) in HIV 1 reverse transcriptase40. Cordell et al.41 proved that 
swertifrancheside (24) binds to DNA to mediate inhibition, thus the xanthone scaffold 
plays a vital role in swertifrancheside (24) activity, as it provides a source of 
intercalation with DNA, due to the xanthone aromaticity. Although, not as potent as 
AZT triphosphate, it has no appreciable cytotoxicity to mammalian cells, making it a 
desirable candidate for clinical development. 
 
MACLURAXANTHONE B AND MACLURAXANTHONE C 
Macluraxanthone B (25) and macluraxanthone C (26) are prenylated xanthones which 
were first isolated by Boyd and co-workers in 2000 from the bark of Maclura 
tinctoria43. 
 
Macluraxanthone B (25) and macluraxanthone C (26) were subjected to a primary 
anti-HIV screen, and showed good potential with EC50 levels of 1.1-2 μg.ml-1. The 
catechol functionality of macluraxanthone B (25) and macluraxanthone C (26) appear 
to offer enhanced HIV inhibitory activity but exhibit high toxicity toward CEM-SS 
host cells with IC50 levels of 2.2 - 3.7 μg.ml-1. 
12 
 
 
 
Figure 11: The structures of macluraxanthone B (25) and macluraxanthone C (26). 
 
ANTI MALARIA XANTHONES 
 
The great panacea of malaria treatment, would be the development of a long lasting 
vaccine. Xanthones express potent activity against the malaria parasite P. falciparum 
and in particular chloroquine resistant strains44, making them important leads in the 
discovery of the next anti-malarial. 
 
F2C5 
Malaria is caused by protozoan parasites of the genus Plasmodium, which specifically 
attack erythrocytes. P. falciparum is responsible for over 80% of  malaria cases 
worldwide and it causes the most severe, often fatal form of the disease45. 
 
The digestive vacuole is an acidic proteolytic compartment central to the metabolism 
of the plasmodium parasite and may be considered as its Achilles heel46. In this 
vacuole haemoglobin is degraded to provide amino acids for parasite growth in a 
process known as hemoglobinolysis. Hemoglobinolysis also yields toxic heme (28), 
which serves as a reservoir of iron for ferroproteins. Although most of the heme is 
detoxified via polymerization into insoluble hemozoin45.  
 
Riscoe and co-workers have synthesized the xanthone 3,6-bis(ω-N,N-
diethylaminoamyloxy)-4,5-difluoroxanthone (F2C5) (27)47. F2C5 (27) was tested 
against multidrug resistant malaria strains W2 and D6 of P. falciparum and IC50 
values of 150 nM and 93 nM were obtained for the respective strains. 
 
13 
 
 
Figure 12: The structure of F2C5 (27). 
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Figure 13: The structure of heme (28). 
 
The xanthone structure of (27) is vital to anti-malarial activity. It is believed that the 
carbonyl bridge co-ordinates to the heme (28) iron atom. The aromatic rings on either 
side of the carbonyl bridge undergo π-π stacking with co-planar aromatic rings of the 
heme (28)44. The introduction of protonable amine chains of five carbon length adds 
to the reactivity of (27) because of the ionic interaction with heme (28) propionate 
groups and for targeting the drug to the parasites acidic vacuole44. The placement of 
halogens, in this case fluorine, improved activity because they are considered 
isosteres of phenolic groups in biological systems45. Secondly, placement of one or 
more halogens on the xanthone nucleus should diminish the likelihood of biological 
oxidations at these positions and thirdly halogens may facilitate complexing to heme 
(28) by mesomeric and/or inductive effects48.  
 
Thus the xanthone scaffold is pivotal in the activity of a heme poison such as F2C5 
(27) to the malarial life cycle as it positions the molecule in a way that the structural 
features of the molecule can maximize its inhibitory potential. 
 
14 
 
DEMETHYLCALABAXANTHONE AND CALOTHWAITESIXANTHONE 
Demethylcalabaxanthone (29) was first isolated from the root bark of the tree 
Calophyllum caledonicum found in New Caledonia by Ampofo et al.49  in 1986 while 
Dharmaratne et al.50 first isolated calothwaitesixanthone (30) from the root bark of the 
same plant in the same year. 
 
 
Figure 14: The structures of demethylcalabaxanthone (29) and  
calothwaitesixanthone (30). 
 
Demethycalabaxanthone (29) and calothwaitesixanthone (30) were tested against 
chloroquine resistant strain of Plasmodium falciparum and IC50 levels of   0.9 μg.ml-1 
and 1.0 μg.ml-1 respectively, were reported by Hay and co-workers51. They 
hypothesized that the reason for the high anti-malaria activity is the position of the 
hydroxyl groups on the xanthone scaffold. Also effecting the activity is the presence 
of a 1, 1-dimethyl allyl side chain and additional pyranic ring. It’s believed that these 
skeletal additions contribute to the electronic features rather than steric factors. These 
electronic features along with the xanthone nucleus contribute primarily to the 
inhibitory activity against hematin aggregation thus making these xanthones potential 
anti-malarials52. 
 
There are many other biological activities apart from those mentioned in this section 
such as anti-microbial and anti fungal activities. Due to the wide range of bio-
activities, the discovery of many versatile and short synthetic routes to the xanthone 
structure have been developed, some of which will be discussed in the next section 
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SYTHETHIC APPROACHES TO 
XANTHONES 
 
There is an increasing interest in new xanthone type structures due to their diverse 
pharmacological activities3. In the field of medicinal chemistry, the groups of 
compounds that can bind to different classes of receptors have attracted much 
attention53. Xanthones can be considered as potential structures in this field as was 
discussed in the previous section related to their biological activity. Xanthones 
obtained by synthesis represent a significant part of the derivatives described in the 
literature. The main object of xanthone syntheses is not only for the development of 
more diverse and complex bioactive compounds for biological activity and structure-
activity relationship studies but also for other applications in medicinal chemistry, 
such as preparation of fluorescent probes, due to the photochemical properties of 
xanthones54. 
 
In this section, a number of synthetic methods for the construction of xanthones will 
be discussed. They will be divided in to three categories; classical methods, non 
conventional methods and new approaches for xanthone synthesis. 
 
CLASSICAL METHODS 
 
One of the first methods for the synthesis of xanthones was introduced by Michael55. 
This involved the distillation of a mixture of a phenol, salycylic acid and acetic 
anhydride to produce simple hydroxyxanthones. The method was poor yielding, 
experimental conditions were harsh and there was a possibility of decarboxylation, 
auto-condensation and other side reactions56. However in 1955, Grover, Shah and 
Shah developed a general method for the synthesis of xanthones that still enjoys great 
popularity today57. 
 
THE GROVER, SHAH AND SHAH REACTION 
The Grover, Shah and Shah reaction offers a convenient method for preparing 
hydroxyxanthones due usually to the accessibility of the starting materials54. It 
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requires a salicylic acid derivative such as (31) and a suitable phenol for example (32) 
and these were heated together with zinc chloride in phosphoryl chloride57. The 
Grover, Shah and Shah method can afford the xanthone skeleton (34) directly only if 
the benzophenone intermediate (33) carries another phenol substituent in an alternate 
site for cyclization (*) (Scheme 4). 
 
 
Scheme 4: (i) ZnCl2, POCl3, 70 °C, 2 h. 
 
There have been recent modifications to the Grover, Shah and Shah reaction39. Better 
results have been reported using a mixture of phosphorus pentoxide-methanesulfonic 
acid (Eaton’s reagent) instead of phosphoryl chloride-zinc chloride as a catalyst. The 
former acylation catalyst was found to be an excellent condensation agent between 
phloroglucinol (32) and 3-methyl-salicylic acid (35) providing high yields of the 
xanthone (36) with no detectable amounts of the related benzophenone54 (Scheme 5). 
 
 
Scheme 5: (i) P2O5, CH3SO3H, 80 °C, 20 min. 
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There are a number of limitations on the original Grover, Shah and Shah reaction such 
as the necessity of a phenolic group to promote direct cyclization and not the 
formation of the benzophenone intermediate58. Although it is possible to cyclize the 
benzophenone intermediate on heating, the overall yields are moderate, thus other 
methods have grown in popularity compared to this one pot synthesis. 
 
SYNTHESIS VIA A BENZOPHENONE INTERMEDIATE 
The benzophenone derivatives are commonly accessible through condensation by 
Friedel-Crafts acylation of an appropriate substituted benzoyl chloride such as (37) 
with anisole (38). Barton et al.59 presented an alternative to the Grover, Shah and 
Shah reaction, involving the formation of 2-hydroxy-2'-methoxy-benzophenones (39) 
followed by the quantitative elimination of methanol in the presence of alkali to give 
the desired xanthone (1) (Scheme 6). 
 
 
Scheme 6: (i) AlCl3, dry ether, rt, 1 h; (ii) NaOH, methanol, reflux, 6 h. 
 
Scheinmann et al.60 demonstrated the usefulness of this reaction by successfully 
synthesizing numerous analogs which were difficult to obtain using the Grover, Shah 
and Shah method due to unwanted demethylations. 
 
The synthesis of benzophenones suitable as precursors for cyclization to xanthones is 
conveniently achieved at room temperature by the Friedel-Crafts acylation of 
methoxybenzene (41) derivatives with the appropriately substituted benzoyl chloride 
(40) in ether (Scheme 7). In cases where acylation occurs adjacent to a methoxy 
group, selective demethylation in the presence of aluminium trichloride occurs at the 
site ortho to the carbonyl group. The fact that extended reaction time (30 h) causes 
ortho-monodemethylation has led to convenient syntheses of substituted 2-hydroxy-
2'-methoxy intermediates such as benzophenone (42) suitable for cyclization to 
substituted xanthones (43) by the elimination of methanol. 
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Scheme 7: (i) AlCl3, dry ether, rt, 30 h; (ii) NaOH, methanol, reflux, 6 h. 
 
Modifications of the Friedel-Crafts reaction have included achieving the acylation 
reaction in the presence of TFAA, demethylations and subsequent cyclization of the 
benzophenone (46) in aqueous medium under pressure and heating61 (Scheme 8). 
 
 
Scheme 8: (i) TFAA, dry CH2Cl2, reflux, 18 h; (ii) BBr3, dry CH2Cl2, –10 °C, 2 h;  
(iii) water, 120 °C, 16 h. 
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Another modification of the reaction was the use of triphenylphosphine in carbon 
tetrachloride as the final bond forming reaction to build the xanthone framework. This 
constituted a new method for the total synthesis of α-mangostin (22). The 
benzophenone (23) was obtained through the parent alcohol (51) by aryl anion 
addition to the substituted benzaldehyde (49), to furnish α-mangostin (22) (Scheme 
9). A slightly different approach involving ortho-lithiation as the key step for the 
synthesis of benzophenones followed by classical cyclization to xanthones was 
utilized31.  
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Scheme 9: (i) s-BuLi, THF, –78 °C; (ii) IBX, toluene: DMSO (1:1), rt;  
(iii) 10% Pd/C, HCO2NH4, acetone, rt; (iv) PPh3, CCl4, THF, silica, rt. 
 
A strategy that has been used with considerable success was accessing the 
benzophenone via a diaryl ester by using a photo-Fries rearrangement (Scheme 10). 
Finnegan et al.62 developed methodology to access 2,5-dihydroxyxanthone (58) via a 
photo-Fries reaction. The 2,3-dimethoxybenzoyl chloride (52) was condensed with 
para-methoxy-phenol (53) to afford the desired diaryl ester (54). The diaryl ester (54) 
underwent a photo-Fries reaction and produced the desired benzophenone (56) in a 
moderate yield of 43% as well as the solvolysis product (55) in 17% yield. 
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Demethylation of (56) followed to form benzophenone (57) which was heated in a 
sealed vessel to give 2,5-dihydroxyxanthone (58). 
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Scheme 10: (i) Pyridine, reflux, 4.5 h; (ii) hν, ethanol, 40 °C, 9 h; (iii) acetic acid, 
HBr, reflux, 4 h; (iv) 225 °C, 17 h. 
 
SYNTHESIS VIA DIARYL ETHERS 
The diaryl ether synthesis of xanthones uses the reaction of phenols such as (60) with 
benzoic acids bearing halogens in the ortho-position, for example (59), and the ring 
formation is accomplished by electrophilic cycloacylation of the initially formed 2-
aryloxybenzoic acid (61)54 as shown in Scheme 11. 
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Scheme 11: (i) Cu, K2CO3, dry DMF, reflux, 3.5 h; (ii) H+, 100 °C, 3 h. 
 
A classical method to produce the ether linkage of the xanthone scaffold is via the 
Ullmann coupling reaction. Reisch and co-workers have prepared xanthone 
derivatives in their synthesis of acronycine isosteres63. For example, 2-chloronicotinic 
acid (63) was coupled with 3,5-dimethoxy-phenol (60) using Ullmann coupling 
procedures to yield (64). This was then cyclized to the xanthone (65) using 
polyphosphoric acid (PPA) (Scheme 12). 
 
 
Scheme 12: (i) Cu, K2CO3, dry DMF, reflux, 3.5 h; (ii) PPA, 100 °C, 3 h. 
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Atwell et al.64 synthesized a xanthone-containing compound using a phase transfer 
reagent in the presence of copper that improves the yield as compared to when using 
ordinary Ullmann conditions. The disodium salt of hydroxyphenylacetic acid (67) and 
the salt of the benzoic acid derivative (66) where submitted to Ullmann coupling 
conditions with the phase transfer catalyst tris[2-(2-methoxy-ethoxy)ethyl]amine 
(TDA-1) to afford (68). This was followed by selective acid catalyzed ring closure to 
yield the desired xanthone (69) as depicted in Scheme 13. 
 
Cl
ONa
O
NaO
(i)
O
HO O
(ii)
O
O
(66) (67)
(68)
(69)
Br O
ONa
Br
O
OH
Br
O
OH
 
Scheme 13: (i) CuCl, TDA-1, dry dioxane, dry DMSO, 110 °C, 12 h; (ii) H2SO4, 
water, 80 °C, 10 min. 
 
Remarkable improvements have been achieved in the synthesis of 1,2-dioxygenated 
xanthones. For example xanthone (74) has been synthesized by the application of a 
direct metallation procedure on diphenyl ether intermediates using lithium di-
isopropylamide (LDA)65. Snieckus and co-workers have accomplished the           
LDA-mediated synthesis of the natural product deoxyjacareubin (74) from the 
appropriate diaryl ether carboxamide (72)65 (Scheme 14). The cyclization step is 
dictated by the coordination effects of direct metallation groups in contrast with the 
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electrophilic substitution of the corresponding carboxylic acids and is driven by 
Complex Induced Proximity Effect (CIPE)66. 
 
 
Scheme 14: (i) CuCl, TDA-1, pyridine, 150 °C, 5 h; (ii) LDA, THF, 0 °C, 1 h;  
(iii) BCl3, CH2Cl2, 0 °C, 1 h; (iv) 3-methyl-but-2-enal, PhB(OH)2, AcOH (1:5), 
toluene, reflux, 16 h; (v) BBr3, CH2Cl2, –78 °C, 1 h. 
 
Elix and co-workers accessed the diaryl ether intermediate (78) via a Smiles re-
arrangement of the diaryl ester (77) en route to xanthone (79)61 (Scheme 15). Ester 
formation was effected by the condensation of the acid (75) and phenol (76) in the 
presence of N, N'-dicyclohexylcarbodiimide (DCC). The diaryl ester (77) was treated 
with potassium carbonate to effect the Smiles rearrangement to the diaryl ether (78). 
Cyclization of the ether (78) by treatment with TFAA gave xanthone (79). 
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Scheme 15: (i) DCC, toluene, dry ether, rt, 24 h; (ii) K2CO3, dry DMSO, 80 °C, N2,  
16 h; (iii) dry toluene, TFAA, rt, 17 h. 
 
NON CONVENTIONAL METHODS 
 
Some so called less conventional methods for the synthesis of xanthones have been 
reported over the years. Although limited in their application to more complex 
xanthone structures, these methods laid the foundation for future and more promising 
work. 
 
SYNTHESIS VIA KETIMINE AND THIOXANTHONE 
As shown in Scheme 16, in 1922 Nishikawa et al.67 synthesized 1,3-
dihydroxyxanthone via a ketimine intermediate. Phloroglucinol (32) was reacted with 
meta-hydroxybenzonitrile (80) in the presence of zinc chloride to afford the ketimine 
derivative (81) in moderate yield. The ketimine (81) was then subjected to aqueous 
basic conditions to effect the formation of the 1,3-dihydroxyxanthone (82). This was a 
new approach to synthesize simple xanthones but the yields were poor and the method 
limited. 
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Scheme 16: (i) Dry ether, ZnCl2, HCl, 2 h; (ii) NaOH(aq), reflux. 
 
Bennet and co-workers synthesized xanthone (85) from thioxanthone (83) 
intermediates68 (Scheme 17). The thioxanthone (83) was treated with a caustic 
solution in dioxane to afford the hydroxybenzophenonesulfinic acid (84). The sulfinic 
acid (84) was then subjected to basic conditions to afford the desired xanthone (85).  
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Scheme 17: (i) NaOH, dioxane-H2O, reflux, 5 h; (ii) NaOH(aq), reflux, 4 h. 
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The thioxanthone (83) was synthesized via a procedure by Amstutz et al.69 as shown 
in Scheme 18. The chlorobenzoic acid (86) was condensed with 4-mecaptobenzoic 
acid (87) in aqueous ethanol to furnish the aldehydo-diphenyl sulphide (88). The 
aldehydo-diphenyl sulphide (88) was heated in concentrated sulphuric acid and 
produced two inseparable products, thiaxanthene (89) and thiaxanthone (90). Both 
thiaxanthene (89) and thiaxanthone (90) were refluxed in acetic acid and hydrogen 
peroxide to give the thioxanthone (83). 
 
Scheme 18: (i) Ethanol(aq), rt, reflux, 75 min; (ii) conc. H2SO4, 60 °C, 30 min;  
(iii) acetic acid, 30% H2O2, reflux, 4 h.  
 
This method was far more flexible than the ketimine method mentioned above in 
terms of functionalizing the xanthone skeleton but the yields were poor and synthesis 
of the starting material was difficult and reaction conditions harsh. 
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CYCLIZATION OF POLY-β-KETONES 
In 1977, Harris et al.70 developed an innovative biomimetic synthetic pathway to the 
naturally occurring secondary metabolite lichexanthone (98) (Scheme 19).  
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Scheme 19: (i) LDA, THF, 0 °C, N2, rt for 16 h; (ii) LDA, THF, 0 °C, N2,  
CO2(g), 10 min; (iii) dry ether, CH2N2,  rt, 1 min; (iv) KOH(aq), rt, 70 h;  
(v) 10% KOH/MeOH, reflux, 7.5 h; (vi) dry ether, CH2N2,  rt, 1 min. 
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They first acylated the dimethyl ether of methyl orsellinate (91) with 
dilithioacetylacetone (92) to give triketone (93). Carboxylation of the trilithium salt of 
triketone (93) gave triketo acid (94) which was esterified to give the ester (95). The 
ester (95) was treated with aqueous KOH which allowed a 1, 6 Claisen cyclization to 
the benzophenone (96) and ring closure was effected with methanolic KOH to give 
the xanthone (97), which was methylated to furnish lichexanthone (98). 
 
Sandifer and co-workers realized the possibilities of cyclizing tetraketones such as 
(102) to xanthones, for example (104)71 (Scheme 20). They successfully synthesized 
the fungal metabolite ortho-methylgriseoxanthone C (104).  
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Scheme 20: (i) NaH, THF, rt, 1 h, N2, reflux for 15 h; (ii) NaH, THF, (92), 0 °C, N2, 
30 min, 40 °C for 22 h; (iii) triethylamine, dry THF, reflux, N2, 38 h; (iv) NaOMe, 
methanol, reflux, N2, 63 h. 
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Reaction between the enolate anion of (99) and dimethyl carbonate (100) afforded the 
β-ketoester (101) which was subsequently acylated with dianion (92) to finally 
produce tetraketone (102). Under mildly basic conditions, tetraketone cyclized to the 
benzophenone (103). A second ring closure to ortho-methylgriseoxanthone C (104) 
occurred when benzophenone (103) was treated with sodium methoxide in methanol. 
 
Although the cyclization of poly-β-ketones was considered a valuable addition to the 
many syntheses of xanthones, its approach is limited to simple xanthones due to the 
problems of many side reactions, poor yields and its inflexibility to more complicated 
xanthone structures. Thus in the last few years, many new approaches to synthesizing 
xanthones have been developed, some of which will be discussed in the next section. 
 
NEW APPROACHES 
 
Different methodologies to construct the xanthone core have emerged in the last two 
decades. The strategies to these methods were to provide an advantage for building 
highly polyoxygenated xanthones with regioselectivity. In this section a few examples 
will be discussed that have totally digressed from the classical approaches and have 
proved to be more successful54. 
 
HAUSER’S METHOD72 
Hauser et al.72 described the reaction between phthalide (106) and benzopyrone (105) 
to produce the natural product bikaverin (2) as portrayed in Scheme 21.  
 
Instead of synthesizing the carbonyl bridge and ether linkage which are distinctive to 
the xanthone nucleus, their approach involved building one of the aromatic rings onto 
the pre-built scaffold. Condensation of the anion of phthalide (106) with the 
chromone (105) furnished the xanthone (107) which was converted into bikaverin (2). 
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Scheme 21: (i) LiOtBu, THF, –78 °C, reflux; (ii) Ag2CO3-celite; (iii) LiI, DMF. 
 
The methodology was extended to angular polycyclic xanthones by condensation of 
benzopyranophthalide (108) with various Michael acceptors (109)73 (Scheme 22). The 
synthesized benzophthalide was treated with LiOtBu and afforded the xanthone (110) 
in good yields.  
 
 
Scheme 22: (i) LiOtBu, THF, –78 °C, Ac2O. 
 
The annulation provides a general, high yielding route to not only xanthones but also 
xanthone containing polycyclic aromatic systems. The use of chromones as Michael 
acceptors expands the utility of the sulfone annulation for regiospecific preparation of 
xanthone systems72. 
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LIEBESKIND-MOORE METHOD74 
Liebeskind et al.74 provided a novel approach to highly fused, highly substituted 
xanthones such as (115) using a process based on the benzannulation of alkenyl, 
aromatic and heteroaromatic lithiates for example (112) with dithiane protected 
benzopyrone-fused cyclobutenediones like (111). The lithiated alkene (112) attacks 
the less hindered carbonyl that also undergoes ortho-acylation to form the 
intermediate (113). The intermediate (113) undergoes a cascade of electrocyclization 
reactions initiated by the ring opening of the cyclobutanone ring to afford 
benzophenone (114) as shown in Scheme 23. The dithiane group was removed and 
the benzophenone (114) underwent internal cyclization eliminating methanol to 
furnish the xanthone (115). 
 
Scheme 23: (i) THF, –78 °C, Ac2O, reflux; (ii) HgCl2/CaCO3,  
mesitylene/H2O, reflux. 
 
Another example using this methodology is the synthesis of the angular fused 
xanthone (121) (Scheme 24). 2-Hydroxyphenylacetaldehyde was protected with 1,3-
propanedithiol to afford dithiane (116), which was reacted with the cyclobutenedione 
(117) to produce adduct (118). Treatment of the intermediate (118) with 2-
lithiodihydrofuran (119) afforded compound (120) regiospecifically. The angular 
fused xanthone (121) was directly formed under the Hg(II)-catalyzed reaction 
conditions used for hydrolyzing the dithiane group.  
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Scheme 24: (i) tBuLi, dry THF, -78 °C; (ii) Ac2O, -78 °C, dry THF, reflux;  
(iii) HgCl2/CaCO3, mesitylene/H2O, reflux. 
 
This is a synthetically flexible approach to highly substituted xanthones which relies 
on cyclobutenediones as scaffolds for the construction of a diverse range of molecular 
structures. The control of regiochemistry combined with short reaction sequence 
make it an attractive approach to naturally occurring xanthones as long as 
cyclobutenediones are available75. However, the availability or synthesis of the 
cyclobutenediones is the limitation of this methodology 
 
CASILLAS’S METHOD76 
Casillas et al.76 developed an alkylnitrilium modification of the Hoeben-Hoesch 
reaction to synthesize xanthone derivatives. Their synthesis was based on the 
reactivity of N-alkylnitrilium salts with activated aromatic rings in a Friedel Crafts 
reaction. This strategy hinges on the reaction of the appropriate arylnitrile (122) and 
an excess of benzoate (123) as shown in Scheme 25. The acylation reaction of 
alkylnitrilium salts surpasses the Hoeben-Hoesch acylation method, shown in the 
prior section during Nishikawa and co-workers’ ketimine synthesis67, owing to the 
enhanced electrophilicity of the intermediate. 
 
33 
 
The nitrilium salt was prepared from 2-fluoro-6-methoxybenzonitrile (122) using the 
Lewis acid SbCl5 in 2-chloropropane. The nitrilium salt (123) was reacted with the 
methyl ester (124) to form the benzophenone ketimine (125), which was treated with 
a base to hydrolyze (125) to the desired xanthone (126). 
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Scheme 25: (i) SbCl5, 2-chloropropane,dry CH2Cl2, rt, 2 h;  (ii) reflux, 60 h, dry 
CH2Cl2; (iii) K2CO3, dry acetonitrile, reflux, 23 h, MeOH/H2O.  
 
The construction and dual protection of the nitrile group provides a general strategy 
for the synthesis of complex xanthone based natural products77. 
 
GHOSH’S METHOD78 
Ghosh et al.78 synthsized xanthones using a Diels Alder [4+2] cycloaddition reaction. 
Their approach was similar to Hauser et al.72; whereby they built the second aromatic 
ring onto the pre-existing carbonyl bridge and ether linkage, contained within a 
chromanone.  
 
The dienamine (127) was reacted with N-phenylmaleimide (128) to form the [4+2] 
cycloadduct which readily eliminates dimethylamine to form the xanthone (130) as 
depicted in Scheme 26. 
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Scheme 26: (i) reflux, DMF, 8 h. 
 
A similar reaction was carried out on an alkyne system79. The dimethyl acetylene 
dicarboxylate (131) with benzopyrone (127) was subjected to Diels Alder conditions 
to give xanthone (134) (Scheme 27). 
 
The formation of the xanthone is due to the benzopyrone (127) behaving like an 
unconjugated amine in undergoing [2+2] cycloaddition with the alkyne (131) to give 
adduct (133) which undergoes ring opening and isomerizes to (132). The ring opened 
intermediate (133) incorporating a pre-existing double bond at the pyran 2,3 position, 
behaves as a hexatriene system and by electrocyclization and subsequent elimination 
of dimethylamine affords xanthone (134). 
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Scheme 27: (i) reflux, DMF, 8 h. 
 
These reactions are successful with both weak and reactive dienophiles and provide 
another useful route of accessing highly substituted xanthones, which ultimately could 
lead to attractive syntheses of more complex naturally occurring xanthones. 
 
These are only a few examples of the new methods that are being used to synthesize 
xanthones. As appealing as many of these methods are, some are limited to 
availability of starting materials and the synthesis of their precursors thus there is 
room for new and other more versatile methods towards the synthesis of xanthone 
containing compounds.  
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AIMS OF PROJECT 
 
Xanthones are an important class of organic compounds. They have diverse biological 
properties, many of which are potential leads to pharmaceuticals against diseases such 
as malaria, HIV-AIDS and various cancers. These pharmacological properties have 
led to many groups researching the synthesis and biological properties of naturally 
occurring and synthetic xanthones, which have been discussed in the previous section. 
 
Earlier in the introduction, the synthesis of bikaverin (2) using a novel route by de 
Koning and co-workers was discussed4. The University of the Witwatersrand (WITS) 
interest for this dissertation was to synthesize other xanthone containing compounds 
using the same route employed in the synthesis of bikaverin (2) by de Koning et al.4. 
We wished to test the flexibility of the methodology towards the synthesis of simple 
xanthone compounds and if successful to apply the methodology to more complex 
xanthones. The synthetic route we initially wished to attempt is illustrated in    
Scheme 28. 
 
As a starting point we wished to assemble the simple xanthones such as (140). For 
this approach salicylic acid and 1,4-naphthoquinone would be our initial starting 
materials. We believed that using a number of simple synthetic steps we would gain 
access to the bridged carbonyl compound (135). This would represent a key 
intermediate on which hydrogenolysis could be performed to afford (136).  We would 
now be in a position to attempt our DDQ mediated reaction.  Hence, phenol (136) 
would be treated with DDQ in an analogous manner to that described by de Koning to 
form spiro-compound (137). Compound (137) would subsequently be hydrolyzed to 
the trione (138) using TFA. The trione (138) we hoped would then undergo pyrolytic 
isomerization at 200oC under reduced pressure to afford the desired xanthone (139), 
which will be oxidized to xanthone (140) using silver(I)oxide in the presence of air. 
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After applying the methodology to hopefully afford simple xanthones, the 
methodology would then be applied to assemble more complex systems such as (143) 
with more complex starting materials such as highly substituted 1,4-naphthoquinones 
(141) and substituted salicylic acids (142) as shown in Scheme 29. 
 
 
Scheme 29 
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The work that was carried out in this MSc using the proposed methodology was 
partially successful but as will be discussed later led to some novel and unexpected 
results, which has opened the door to wider research into this area. These results will 
be discussed in the next chapter. 
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RESULTS AND DISCUSSION 
 
SYNTHESIS OF 12a-METHOXY-5H-BENZO[c]XANTHENE-
5,7(12aH)-DIONE 
 
PREPARATION OF BENZYL 2(BENZYLOXY)BENZOATE 
As a starting point the reactive functional groups on the starting material, salicylic 
acid (144) needed to be masked hence, similar to the procedure used by de Koning et 
al.4, salicylic acid (144) was treated with potassium carbonate in order to deprotonate 
both the phenol and carboxylic acid functional groups. The addition of benzyl 
bromide (146) then resulted in the formation of the desired product (147) as shown 
below in Scheme 30. 
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Scheme 30: (i) K2CO3, acetone, benzyl bromide, reflux, 18 h, N2(g), 87%. 
 
The reaction is a classic electrophilic substitution reaction via an SN2 mechanism 
hence substitution occurred via a transition state rather than an intermediate. The base, 
potassium carbonate, deprotonated both the acid and the phenol and formed an 
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alkoxide ion (145), while the benzyl bromide (146) acted as a suitable electrophile. 
The reaction occurred quite rapidly via the SN2 mechanism.  
 
The 1H NMR spectrum showed two singlets with a chemical shift (δ) at 5.33 ppm and 
5.13 ppm both integrating for 2 protons. These signals are for the methylene groups 
and the peak at 5.33 ppm is slightly deshielded from the peak at 5.13 ppm indicating 
that it is the methylene group bonded to the ester functionality. Inter alia, a doublet of 
doublets is seen at 7.85 ppm integrating for 1 proton. This is hydrogen in the             
6-position of (147). The doublet of doublets was due to ortho- and meta- coupling of 
the hydrogen in the 6-position with the coupling with the hydrogens in the 5- and       
4-position of (147) respectively. This was indicated by the coupling constants of     
7.7 Hz and 1.7 Hz which corresponded to the hydrogen coupling to the hydrogen in 
the ortho- and meta- positions of the aromatic ring respectively. The 13C NMR 
spectrum showed, inter alia, two signals at 66.6 ppm and 70.5 ppm which 
corresponded to the two methylene carbons. The signal at 70.5 ppm appeared further 
downfield because it was bonded to the ester moiety. Another characteristic peak was 
at 166.2 ppm which was due to the carbonyl functional group from the ester moiety. 
There were also four quaternary aromatic carbons at 158.1 ppm, 136.5 ppm,        
136.0 ppm and 128.4 ppm that are unique to our protected salicylic acid (147). The IR 
spectrum showed a strong signal at 1716 cm-1 that was characteristic of a carbonyl 
stretching and two strong signals at 1233 cm-1 and 1072 cm-1 which were 
characteristic of a carbon single bonded to oxygen. The absence of a strong broad 
signal around 3300 cm-1, which was representative of a hydroxy group of the salicylic 
acid (144), suggests that both the carboxylic acid and phenol had been converted into 
an ester and ether respectively. The melting point of 47 ˚C - 49 ˚C was close to that of 
the literature melting point of 50 oC - 51 oC80. The product was confirmed as benzyl 
2-(benzyloxy)benzoate (147). 
 
PREPARATION OF 1,4-DIMETHOXYNAPHTHALENE 
In a parallel synthesis the reactive carbonyls of the 1,4-naphthoquinone (148) needed 
to be protected (Scheme 31). To this effect 1,4-naphthoquinone (148) was first 
reduced to hydroquinone (150) using sodium dithionite via what is believed to be  an 
anionic radical mechanism81. The radical anion initially formed was very basic and in 
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the presence of a proton and a reducing agent, a radical (149) is formed. The radical 
intermediate (149) is then provided with another electron and forms an anion, which 
ultimately obtains a second proton and forms hydroquinone (150). The key to the 
reduction is that electrons can reduce any functional group with a low energy π 
antibonding orbital, such as carbonyls, into which electrons could enter. The product 
(150) was immediately used in the next step of the reaction because the hydroquinone 
(150) would be oxidized back to the 1,4-naphthoquinone (148) by air. 
 
 
Scheme 31 
 
The reaction of dimethyl sulfate (152) with hydroquinone (150) is essentially an 
electrophilic substitution similar to that of benzyl bromide (146) with salicylic acid 
(144) (Scheme 30). The potassium carbonate abstracts the acidic phenolic proton to 
form the hydroquinone anion (151). This reacts with the electrophilic methyl 
substituent of dimethyl sulfate (152) to ultimately form 1,4-dimethoxynaphthalene 
(153) as shown in Scheme 32. 
 
 
Scheme 32: (i) (CH3)2SO4, acetone, K2CO3, reflux, 18 h, N2(g), 85%. 
 
The reaction proceeded smoothly to give (153) in 85% yield. 
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The 1H NMR spectrum showed a singlet at 4.00 ppm which integrated for 6 protons, 
characteristic of the two methoxy groups at the 1- and 4-positions of (153). Another 
singlet occurred at a chemical shift of 6.73 ppm for the hydrogens in the 2- and         
3-position of (153). These singlets occurred due to the symmetry of the molecule thus 
there is no coupling between these two hydrogens. The 13C NMR spectrum showed 
two quaternary signals at 149.5 ppm and 126.4 ppm. The peak at 149.5 ppm 
corresponded to the carbon attached to the methoxy groups at the 1- and 4-positions 
therefore it is further downfield from the other quaternary peak at 126.4 ppm, which is 
due to the bridging carbons. Another signal at 55.7 ppm was characteristic of a 
methoxy group. The absence of quaternary signals around 160-180 ppm indicated the 
absence of the quinone carbonyl. The IR spectrum showed the absence of a sharp 
peak around 1700 cm-1 which was characteristic of ketone vibrational stretching but 
showed two strong signals at 1058 cm-1 and 1231 cm-1 which are due to a carbon 
single bonded to oxygen, which suggests that the quinone has successfully been 
converted into an aromatic ether. The product was confirmed as                             
1,4-dimethoxynaphthalene (153).   
 
SYNTHESIS OF 2-(BENZYLOXY)BENZOIC ACID 
The ester (147) was selectively deprotected by base catalyzed hydrolysis of the ester 
moiety to its corresponding carboxylic acid (155). The base catalyzed hydrolysis of 
the ester was irreversible (Scheme 33). The tetrahedral intermediate (154) could give 
back the ester (147) or go in a forward sense to the carboxylic acid (155). Under basic 
conditions the formation of the acid was irreversible as it was deprotonated to form 
the carboxylate salt (156) that was hydrolysed in a separate reaction to the 
corresponding benzoic acid (155) upon work up with acid. Due to the formation of the 
carboxylate salt (156), at least one mole equivalent of base was required. 
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Scheme 33: (i) 12% KOH/methanol, reflux, 18 h, N2(g), HCl, 86%.  
 
The 1H NMR spectrum showed a broad singlet at 10.71 ppm, which integrated for      
1 proton that corresponded to the hydroxy group. A singlet at 5.48 ppm was 
characteristic of the methylene group from the remaining benzyl ether. The doublet of 
doublets has shifted downfield from 7.85 ppm to 8.14 ppm was assigned to the proton 
on the aromatic ring in the 6-position of (155), since it was adjacent to a carbon at the 
carboxylic acid rather than an ester. The absence of second singlet at about 5.00 ppm 
suggested that the benzyl group attached to the ester moiety had been cleaved and the 
ester successfully hydrolyzed to the carboxylic acid (155) without the removal the 
second benzyl group. The 13C NMR spectrum showed four quaternary peaks at 166.2 
ppm, 157.6 ppm, 134.7 ppm and 118.1 ppm, one less than the starting material. The 
peak at 166.2 ppm corresponded with the carbonyl group of the carboxylic acid (155) 
while the peak at 118.1 ppm corresponded to the quaternary aryl carbon of the benzyl 
group. A characteristic peak in the 13C NMR spectrum at 72.02ppm was due to a 
methylene group. The absence of a second peak in the region suggested that the 
second benzyl substituent had been successfully hydrolyzed. The IR spectrum showed 
a strong broad peak at 2970 cm-1 which was due to a hydroxy bond stretching band. 
The broad peak was due to the hydroxy peak hydrogen bonding to the carbonyl group 
of another molecule. The strong sharp peaks at 1674 cm-1 and 1232 cm-1 are 
characteristic of carbonyl stretching and a carbon single bonded to oxygen 
respectively. The melting point of 72˚C - 75˚C was identical to that of the literature 
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value of 73.5˚C – 74.5˚C and suggested that the reaction was successful82. The 
product was confirmed as 2-(benzyloxy)benzoic acid (155). 
 
SYNTHESIS OF (2-(BENZYLOXY)PHENYL)(1,4-
DIMETHOXYNAPHTHALEN-2-YL)METHANONE USING TFAA 
The building of the carbonyl bridge of the xanthone nucleus was one of the key 
reactions of our synthesis. de Koning et al.4 used trifluoroacetic anhydride (TFAA) 
(160) together with 2-benzyloxy-4-methoxy-6-methylbenzoic acid (5) and 1,2,4,5,8-
pentamethoxynaphthalene (4) to form the carbonyl bridge between the two 
compounds in reasonable yield (Scheme 34). 
 
 
Scheme 34: (i) TFAA, dry CH2Cl2, rt, 90 h, 51%. 
 
Sundholm83 had shown that aromatic acylation using an oxygenated benzene 
compound such as 1,3,5-tris(benzyloxy) benzene (158) and a substituted benzoic acid 
(157) in the presence of TFAA also proceeded to give the carbonyl bridged compound 
(159) in very high yield (Scheme 35).  
 
Scheme 35 
 
The 1,4-dimethoxynaphthalene (153) is not as electron rich as the 1,2,4,5,8- 
pentamethoxynaphthalene (4) and the Friedel-Crafts type reaction with TFAA 
proceeds best with highly oxygenated systems. Thus the 1,4-dimethoxynaphthalene 
(153) used in the reaction was a poorer nucleophile than 1,2,4,5,8- 
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pentamethoxynaphthalene (4) used by de Koning et al.4 and this was a possible reason 
attributed to the poor yield of 30% obtained in this reaction. 
 
The first step in this reaction was to form the mixed anhydride (162) which was 
pivotal to the Friedel Crafts reaction between the 1,4-dimethoxynaphthalene (153) 
and the 2-(benzyloxy)benzoic acid (155) (Scheme 36). The nucleophilic oxygen from 
the carboxylic acid (155) added to the electrophilic carbonyl group of the 
trifluoroacetic anhydride (160) and formed a tetrahedral intermediate (161). The 
tetrahedral intermediate (161) was highly unstable and underwent an elimination of 
trifluoroacetic acid (TFA). The elimination of the trifluoroacetate anion and the 
proton resulted in the formation of the desired mixed anhydride (162). 
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Scheme 36: (i) TFAA, dry CH2Cl2, rt, 48 h. 
 
As fluorine is very electronegative the carbonyl adjacent to the aromatic ring is more 
susceptible to nucleophilic attack hence the 1,4-dimethoxynaphthalene (153) acted as 
the nucleophile to initially form the intermediate (163), which aromatized to afford 
the required ketone (135) (Scheme 37).  
 
The diacylated and triacylated products reported by de Koning et al.4 in their 
synthesis were not produced. Only the starting materials and the desired ketone (135) 
formed in 30% yield were recovered through column chromatography. 
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Scheme 37: (i) TFAA, dry CH2Cl2, rt, 48 h, 30%. 
 
The 1H NMR spectrum showed singlets at a chemical shift of 3.91 ppm and 3.59 ppm. 
These singlets corresponded to the methoxy groups at the 1'- and 4'-positions of (135) 
as they integrated for 3 protons each. The singlet at 3.91 ppm appeared downfield 
because of the presence of the carbonyl group attached to the 2'-position which 
deshielded the methoxy group. Another singlet with a chemical shift of 4.89 ppm was 
characteristic of the methylene group from the benzyloxy substituent (155) as it 
integrated for 2 protons. A doublet appeared at 6.74 ppm and was due to the hydrogen 
at the 3-position coupling with the hydrogen at the 4-position as the signal integrated 
for 1 proton. Another doublet appeared at 7.69ppm and was due to the hydrogens at 
the 8'-positions as well as the 5'-positions of (135). The molecule is symmetrical in 
the region therefore the doublet integrated for 2 protons. The doublet formed by the 
hydrogen in the 5'-position coupling with the hydrogen in the 6'-position and the 
hydrogen in the 7'-position coupling with the hydrogen in the 8'-position exhibited 
identical shifts. A characteristic shift was the singlet at 6.87 ppm which was due to the 
isolated hydrogen in the 3'-position of (135). These shifts verified that the 1,4-
dimethoxynaphthalene (153) had reacted with the 2-(benzyloxy)benzoic acid (155). 
The 13C NMR spectrum showed a peak at 196.3 ppm which was characteristic of a 
ketone carbonyl. The peaks at 55.8 ppm and 63.6 ppm corresponded to the carbons of 
the methoxy groups while the peak at 70.3 ppm was due to the carbon from the 
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benzyloxy methylene. Two signals at 150.3 ppm and 151.7 ppm were due to the 
carbons on the naphthalene ring attached to the methoxy substituents, while a signal at 
157.5 ppm corresponded to the benzyl ether carbon. These shifts proved that the 
carbonyl bridge was formed between the   2-(benzyloxy)benzoic acid (155) and 1,4-
dimethoxynaphthalene (153). The IR spectrum showed a strong sharp signal at 1734 
cm-1 which was characteristic of carbonyl stretching vibrations. The peaks at 1290 
cm-1 and 1096 cm-1 were due to carbon single bonded to oxygen stretching vibrations 
from the methoxy and benzyloxy groups respectively. There was an absence of a 
strong broad peak at 3000 cm-1 thus the absence of the hydroxyl group from the 
carboxylic acid also suggested that the carbonyl bridge was formed. The mass 
spectrum showed an ion of 398.1523 which correlated with the calculated mass, 
398.1518 of the desired ketone (135). The product was thus confirmed as (2-
(benzyloxy)phenyl)(1,4-dimethoxynaphthalen-2-yl)methanone (135). 
 
Although the reaction was successful, the yields were poor with a maximum yield of 
30%, when the reaction was heated under reflux in chloroform for 90 hours. Apart 
from the poor yields, separation of the ketone (135) from the starting material was 
arduous involving extensive use of column chromatography. To test the flexibility of 
the entire synthetic route, another method was sought to form the ketone (135). 
 
In their pursuit to successfully synthesize nigrolineaxanthone F (164) and 
osajaxanthone (165), Argade and co-workers formed the carbonyl bridge of the 
xanthone nucleus to yield (168) by reacting n-butyllithium with 2-bromo-1,3,5-
trimethoxybenzene (166) followed by methyl-2,5-(dibenzyloxy)benzoate (167)84 
(Scheme 38).  
 
 
Figure 15: The structure of nigrolineaxanthone F (164) and osajaxanthone (165). 
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We therefore decided that the carbonyl bridge could be formed using similar 
methodology by first brominating 1,4-dimethoxynaphthalene (153) and then under the 
same conditions as described above by reacting it with benzyl 2-(benzyloxy) benzoate 
(147). 
 
 
Scheme 38: (i) n-BuLi, dry THF, –78 °C,1.5 h. 
 
SYNTHESIS OF 2-BROMO-1,4-DIMETHOXYNAPHTHALENE 
Bloomer et al.85 have used N-bromosuccinimide (NBS) (169) as a mild brominating 
reagent for polyalkoxyaromatic systems such as 1,4-dimethoxynaphthalene (153) as 
shown in Scheme 39. The reaction is believed to occur through an electrophilic 
substitution process. The naphthalene system was not very reactive and would only 
react with good electrophiles such as cationic bromine. The methoxy groups at the 1- 
and 4-positions of the naphthalene ring donate electron density into the ring and were 
thus ortho-directors. One mole equivalent of NBS (169) was added and due to the 
symmetry of 1,4-dimethoxynaphthalene (153) only one product was formed. The 
NBS (169) provided the electrophilic bromine that reacted with the 1,4-
dimethoxynaphthalene (153) at the 2-position and produced the cation intermediate 
(170). The loss of the proton from the cation intermediate restored the aromaticity and 
furnished 2-bromo-1,4-dimethoxynaphthalene (171). 
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Scheme 39: (i) NBS, dry CH2Cl2, rt, 18 h, 90%. 
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The 1H NMR spectrum showed two singlets at a chemical shift of 3.97 ppm and    
3.98 ppm that integrated for 3 protons each. These signals suggested that the 
symmetry of the 1,4-dimethoxynaphthalene (153) was now absent. A singlet appeared 
at 6.91 ppm and integrated for 1 proton and corresponded to the single proton at the 3-
position of (171). The 13C NMR spectrum showed five quaternary carbon signals at 
152.1 ppm, 146.6 ppm, 128.9 ppm, 125.7 ppm and 111.8 ppm. The signals at 152.1 
ppm and 146.6 ppm were characteristic of the carbons bonded to the methoxy groups, 
while the signal at 111.8 ppm was due to the carbon bonded to the bromine rather 
than hydrogen. Two signals at 61.3 ppm and 55.7 ppm corresponded to the carbons of 
the two methoxy groups. The IR spectrum showed a strong sharp peak at 773 cm-1 
that was due to a carbon single bonded to a halide stretching vibration. The strong 
signal at 1105 cm-1 was characteristic of a carbon single bonded to oxygen stretching 
vibration and was attributed to the methoxy group. The melting point of 56˚C - 58˚C 
was very close to that reported in the literature of 54˚C - 55˚C and suggested that the 
desired product was formed86. The product was confirmed as 2-bromo-1,4-
dimethoxynaphthalene (171). 
 
SYNTHESIS OF (2-(BENZYLOXY)PHENYL)(1,4-
DIMETHOXYNAPHTHALEN-2-YL)METHANONE USING n-BUTYL 
LITHIUM 
The carbonyl bridge of the xanthone nucleus of (135) was synthesized in two steps 
from naphthalene (171). Firstly, the organometallic reagent (173) needed to be 
synthesized (Scheme 40). The methoxy functional group guided the butyllithium, so 
that it attacked the adjacent bromine. This was done via a presumed complex (172) 
formed between the oxygen from the methoxy group and the electron deficient 
lithium atom. The complexation facilitates lithium-halogen exchange. 
 
 
Scheme 40: (i) n-BuLi, dry THF, –78 ˚C, N2(g), 1.5 h. 
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The 2-bromo-1,4-dimethoxynaphthalene (171) underwent lithium-halogen exchange 
to form the lithiated product (173). The second step was then the slow addition of the 
lithiated product (173) to the benzyl 2-(benzyloxy)benzoate (147) (Scheme 41). 
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Scheme 41: (i) n-BuLi, dry THF, –78 ˚C, N2(g), 1.5 h, 89%. 
 
It was important that the organolithiated compound (173) as added slowly to the 
benzyl 2-(benzyloxy)benzoate (147) to prevent the very reactive lithiated 1,4-
dimethoxynaphthalene (173) from adding twice to the ester (147). Another factor that 
prevented the second addition was the presence of the bulky benzyloxy group that 
could have caused steric hindrance and worked in the favour of a single addition. The 
nucleophilic lithiated 1,4-dimethoxynaphthalene (173) attacked the carbonyl and 
formed the tetrahedral intermediate (174) that readily eliminated the benzyloxy anion 
and furnished the desired  protected ketone (135)  in 89% yield. 
 
The 1H NMR, 13C NMR and IR spectra all correlated exactly to that of the  product 
(135) formed using TFAA in the Friedel-Crafts reaction. 
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SYNTHESIS OF (1,4-DIMETHOXYNAPHTHALEN-2YL)(2-
HYDROXYPHENYL) METHANONE  
The benzyl group had to be removed to prepare the compound for the next step that 
involved utilizing DDQ. Palladium on carbon under a hydrogen atmosphere of 4.5 
bars was chosen as it is a clean and efficient method for the removal of O-benzyl 
groups in our laboratories and therefore should provide the same results for our 
benzyl substituent (135). The palladium was precipitated onto the carbon. The 
palladium provided maximum surface area for the reaction it catalysed. The hydrogen 
was adsorbed onto the surface of the metal.  
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Scheme 42: (i) 5% Pd/C, H2(g), dry methanol, 5 atm, 18 h, 97% 
 
It is believed that the benzyloxy group is co-ordinated to the metal catalyst via the 
electron rich aromatic ring. The carbon oxygen bond was now in close proximity to 
the palladium and under these conditions furnished the required phenol (136) and 
toluene (176) (Scheme 42). Initial co-ordination with the catalyst was needed 
therefore only benzylic or allylic carbon oxygen bonds can be reduced. Due to the 
high pressures the reaction was carried out in a Parr hydrogenator. 
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The 1H NMR spectrum showed two singlets at 3.94 ppm and 3.81 ppm which 
correlated to the two methoxy groups at the 1'- and 4'-positions of (136). The absence 
of the singlet at around 5.00 ppm was noteworthy as this was characteristic of the 
methylene group from the benzyl substituent and suggested that the benzyl protection 
group was removed. There was a singlet that integrated for 1 proton downfield at 
12.25 ppm and was assigned to the hydroxyl group at the 2-position of (136). The 
hydroxyl group exhibited a sharp signal rather than the characteristic broad signal 
associated which the hydroxyl group that appeared around 9.00 ppm, in 2-
(benzyloxy)benzoic acid (155). This was due to the intramolecular hydrogen bonding 
between the hydrogen of the hydroxyl group and oxygen of the carbonyl group of the 
product (136). The singlet at 6.68 ppm in the spectrum was assigned to the proton at 
the 3'-position as it is flanked by the carbonyl functionality and the methoxy group at 
the 4'-position. The doublet at 7.05 ppm corresponded to the proton adjacent to the 
hydroxyl group in the 3-position, while the triplet at 6.78 ppm was due to the proton 
at the 5-position of (136).  The 13C NMR spectrum showed a peak at 202.4 ppm 
which indicative of a carbonyl signal while the peaks at 63.7 ppm and 55.8 ppm were 
due to the carbons attached to the methoxy groups while the absence of the peak at 
around 70 ppm, characteristic of a methylene group suggested the removal of the 
benzyl protecting group. A quaternary carbon signal at 163.1 ppm appeared while a 
quaternary signal at 157.2 ppm disappeared indicating that an aromatic carbon was 
still bonded to an oxygen atom and hence a phenolic substituent could be present. The 
IR spectrum showed a broad peak at 2970 cm-1 that correlated to a phenol group while 
the characteristic sharp peak at 1739 cm-1 was indicative of carbonyl stretching 
vibrations. The mass spectrum showed an ion of 308.1048 which correlated with the 
calculated mass, 308, 1049 of the desired ketone (136). The product was confirmed as 
(1,4-dimethoxynaphthalen-2-yl)(2-hydroxyphenyl)methanone (136) by X-ray 
crystallography. 
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Figure 16: ORTEP diagram for the crystal structure of the (1,4-
dimethoxynaphthalen-2-yl)(2-hydroxyphenyl)methanone (136) 
 
The crystal structure of (136) (Figure 16) showed the hydrogen bonding between the 
hydrogen connected to O4 from the phenol group with the oxygen O3 from the 
carbonyl group. It was clear that free rotation around the bond between C4 and C5 as 
well as C5 and C6 occurred in solution. As will be discussed later, this was important 
as the molecule can arrange itself in a manner to allow for one the methoxy group of 
the naphthalene ring to be in close proximity to the phenolic substituent which would 
prove strategically vital in the formation of our final product as shown schematically 
in Scheme 43. 
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Scheme 43 
 
ATTEMPTED SYNTHESIS OF 4'-METHOXY-1'H,3H-
SPIRO[BENZOFURAN-2,2'-NAPHTHALENE]-1',3(3'H,8a'H)-DIONE 
The formation of the spiro-compound with the use of DDQ (186) as an oxidizing 
agent was a key step in the synthesis of bikaverin (2) by de Koning et al.4. Lewis and 
co-workers showed that 2-hydoxy-3-methoxybenzophenones (177) underwent 
intramolecular oxidative cyclization with 2,3-dichloro-5,6-dicyanobenzoquinone 
(DDQ) (186) to form corresponding methoxyxanthones (178) and (179)87, 
unfortunately as a mixture of products (Scheme 44).  
 
 
Scheme 44 
 
Lewis et al.88 later showed that the benzophenone (180) upon oxidation with 2,3-
dichloro-5,6-dicyanobenzoquinone (DDQ) (186) yielded two products, the xanthone 
(181) and the spiro-compound (182) which in turn was converted into the xanthone  
(181) upon heating (Scheme 45). 
 
 
Scheme 45 
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de Koning et al.4 applied the methodology used by Lewis on a more complex system 
to form the spiro-enol ether (8) from the hydroxymethanone (7) in a 61% yield 
(Scheme 46). The mechanism postulated for the formation of the spiro-enol ether (8) 
was similar to that described by Becker89 as shown in Scheme 47. 
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Scheme 46 
 
 
Scheme 47 
 
The naphthol (7) underwent transfer of a hydrogen atom to give the phenoxy radical 
(184) and the 2,3-dichloro-5,6-dihydroquinone radical (183). The two radicals 
combined to yield the 2,3-dichloro-5,6-dicyanobenzoquinone phenol adduct (185) 
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under the reaction conditions, the ketal  (185) collapsed and formed the spiro-enol 
ether (8).  
 
 
Scheme 48: (i) dry benzene, DDQ, rt, 72 h; (ii) dry benzene, DDQ, reflux, 72 h;  
(iii) dry chloroform, DDQ, rt, 72 h; (iv) dry chloroform, DDQ, reflux, 72 h 
 
Hence the reaction of (136) with DDQ (186) was a pivotal step in this project for the 
formation of the ether linkage of the xanthone. Our intermediate (136) was subjected 
to the same conditions used by de Koning and Lewis but this only gave back starting 
material. The solvent was changed to chloroform and the reaction was brought to 
reflux for the 72 hours but only starting material was recovered (Scheme 48). 
Therefore we had to change the direction of the project and pursue other leads. 
. 
 
Scheme 49 
 
Whalley and co-workers have found that 1,4-benzoquinones such as (187) undergo 
1,4 Michael addition to afford the xanthone for example (188)90 (Scheme 49). 
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After the lack of success using DDQ (186) as a reagent, a decision was made to 
oxidize the methoxy groups using another oxidizing agent such as ceric ammonium 
nitrate (CAN), to hopefully form the quinone (189) which would undergo either the 
1,4-addition or the formation of the spiro-compound (138) which could be 
transformed to the xanthone (139) upon heating (Scheme 50). 
 
SYNTHESIS OF 12a-METHOXY-5H-BENZO[c]XANTHENE-5,7(12aH)-
DIONE USING CERIC AMMONIUM NITRATE 
Ceric ammonium nitrate is an excellent oxidizing agent for hydroquinone dimethyl 
ethers due to its selectivity, efficiency and mildness of reaction conditions. Castagnoli 
Jnr and co-workers successfully showed the application of CAN as an oxidizing agent 
and even formulated a basic mechanism for the reaction91. The reaction mechanism 
was exactly opposite to that reported earlier on by Waldhor et al.81 and occurred via a 
cationic radical mechanism. Oxidation of 1,4-dimethoxy-2,3,5,6-tetramethylbenzene 
(190) in the presence of 95% isotopically rich H2O (O18) provided doubly labelled 
deuterated benzoquinone (191). Consequently the reaction proceeded by aryl-oxygen 
bond cleavage with a net formation of the quinone and 2 moles of methanol. CAN 
acted as a one electron transfer reagent by producing hydroxyl radicals from the 
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water. The oxidation allows the hydroxyl radical to attack (192)92. As shown in 
Scheme 51 this process occurs twice. 
 
 
Scheme 51 
 
When (136) was treated with ceric ammonium nitrate in aqueous acetonitrile, it was 
monitored by TLC over an hour. After an hour all the starting material had been 
consumed as shown by TLC and a new fluorescent spot appeared below the starting 
material spot when irradiated with UV light.  We expected the product to be (189) or 
possibly the xanthone (139) or the oxidized xanthone (140) (Scheme 52).   
 
 
Scheme 52: (i) CAN, acetonitrile, rt, 1.5 h, 72%. 
 
Surprisingly the 1H NMR spectrum still showed a singlet at 3.03 ppm that integrated 
for 3 protons. This corresponded to one methoxy group, while the absence of another 
singlet in the region suggested that neither (139), (140) nor (189) had been formed. 
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The methoxy group at 3.03 ppm appeared further upfield than its usual chemical shift 
around 3.50 - 4.00 ppm. It was discovered later that the unusual chemical shift was 
due to the methoxy group being a constituent of a hemiacetal. A puzzling signal 
appeared as a singlet at 7.26 ppm which integrated for 1 proton which was consistent 
for a quinone proton. Furthermore the doublet at 8.16 ppm was characteristic of the 
hydrogen adjacent to the carbonyl bridge of a xanthone as it was deshielded by the 
carbonyl. The absence of the singlet at around 12.00 ppm combined with the unusual 
shift of the methoxy group suggested that probably the ether linkage of the xanthone 
was formed. The 13C NMR spectrum showed two quaternary signals at 184.0 ppm and 
181.0 ppm that corresponded to carbonyl chemical shifts. This suggested that the one 
methoxy substituent was oxidised to the carbonyl. A signal at 51.4 ppm was 
characteristic of a methoxy group while a confusing quaternary signal at 96.4 ppm 
suggested that an acetal could be present. A quaternary signal at 157.8 ppm was 
characteristic of a carbon single bonded to oxygen was also evident. The IR spectrum 
showed a sharp signal at 1738 cm-1 that was due to carbonyl stretching vibrations. The 
absence of a broad band around 3000 cm-1 corresponded to the absence of the 
hydroxyl group in the product while there were three sharp signals at 1129 cm-1, 1099 
cm-1 and 1023 cm-1 that corresponded to carbon singly bonded to oxygen stretching 
vibrations. 
 
The spectroscopy data was still very inconclusive and unexpected thus a crystal 
structure was obtained on the unknown product and it revealed an unexpected 
structure indicating that the acetal had been formed containing two carbonyl 
substituents (Figure 17). The mass spectrum showed an ion of 276.0778 which 
correlated with the calculated mass, 292.0736 of the crystal product (193) minus an 
oxygen. The product was confirmed as the angular fused xanthone 12a-methoxy-5H-
benzo[c]xanthene-5,7(12aH)-dione (193) . An optical rotation was carried out on the 
crystal revealing a rotation of  -7.2 which confirmed the stereogenic centre at C2. 
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Figure 17: ORTEP diagram for the crystal structure of the 12a-methoxy-5H-
benzo[c]xanthene-5,7(12aH)-dione (193) 
 
The following mechanism was proposed. The hydroxyketone (136) is oxidized to 
intermediate (194) consistent with the proposed mechanism. The intermediate (194) 
undergoes elimination of water by way of the nucleophilic oxygen attacking the 
electrophilic carbon attached to the hemiacetal and thus a xanthone like compound 
(195) was produced. The hemiacetal of the xanthone (195) then undergoes the 
elimination of methanol to furnish our product (193) in good yield as the only product 
(Scheme 53).  
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After the surprising results obtained, the decision was made to try the reaction on 
related substrates to gauge the versatility of this novel reaction. 1,4-
Dimethoxybenzene (196) could be used instead of 1,4-dimethoxynaphthalene (153) in 
this investigation since it is commercially available. 
 
SYNTHESIS OF 2-METHOXY-9H-XANTHENE-9-ONE AND 
4a-METHOXY-2H-XANTHENE-2,9(4aH)-DIONE 
 
The decision was made to further explore the efficiency and flexibility of the reaction 
after the surprising results obtained with the use of ceric ammonium nitrate. 1,4-
Dimethoxybenzene (196) which was commercially available was used instead of 1,4-
dimethoxynaphthalene (153) as a starting point.  
 
1,4-Dimethoxybenzene (196) was brominated with NBS by way of an electrophilic 
substitution reaction to furnish 2-bromo-1,4-dimethoxybenzene (197) as a colourless 
liquid in excellent yields via the method used by Bloomer and co-workers85     
(Scheme 54). 
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Scheme 54: (i) NBS, dry CH2Cl2, reflux, 24 h, 89%. 
 
The 1H NMR spectrum showed two singlets at 3.74 ppm and 3.82 ppm respectively 
that integrated for 3 protons each. These signals corresponded to the two methoxy 
groups at the 1- and 4-position of (197), which suggested that the symmetry of the 
compound was now absent. A singlet at 7.11 ppm which was due to the hydrogen in 
the 3-position was also evident. The 13C NMR spectrum showed three quaternary 
signals at 154.0 ppm, 150.3 ppm and 113.6 ppm. The peaks at 154.0 ppm and      
150.3 ppm were characteristic of aromatic carbons bonded to methoxy groups, while 
the peak at 113.6 ppm suggested that a halogen was attached to an aromatic carbon. 
The IR spectrum showed a strong sharp signal at 730 cm-1 which was due to carbon 
single bonded to bromide stretching vibrations. The compound was confirmed to be 
2-bromo-1,4-dimethoxybenzene (197). 
 
The next step was to form the carbonyl bridge between 2-bromo-1,4-dimethoxy 
benzene (197) and benzyl 2-(benzyloxy)benzoate (147) to furnish the benzyloxy 
ketone (201) (Scheme 55). The 2-bromo-1,4-dimethoxybenzene (197) was lithiated 
and then added to the benzyl 2-(benzyloxy)benzoate (147) to form the tetrahedral 
intermediate (199), which immediately eliminated the benzyloxy anion and furnished 
the desired product (200) as shown in Scheme 56. 
 
 
Scheme 55: (i) nBuLi, dry THF, –78°C, 30 min 
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Scheme 56: (i) dry THF, –78 °C, 45 min, 72%. 
 
The 1H NMR spectrum showed two singlets at 3.75 ppm and 3.52 ppm which 
integrated for 3 protons each and corresponded to the two methoxy groups at the       
2- and 5-positions of (200). The singlet 3.75 ppm appeared slightly downfield because 
it was deshielded by the adjacent carbonyl group attached at the 1-position. A singlet 
at 4.94 ppm which was characteristic of a methylene group as it integrated for two 
protons. The singlet was due to the benzyl substituent and suggested that the carbonyl 
bridge was formed. The doublet of doublets at 7.59 ppm was due to the hydrogen at 
the 6'-position of (200). The signal appeared as a doublet of doublets due to ortho-
coupling with the hydrogen in the 5'-position that was verified by a coupling constant 
of 7.6Hz and meta-coupling with the hydrogen in the 4'-position that was verified by a 
coupling constant of 1.7Hz.  Another doublet appeared at 6.76 ppm and was due to 
the hydrogens at the 3- and 4-positions of (200) coupling with one another. The signal 
appeared as one doublet integrating for 2 protons because the molecule was 
symmetrical in this region and thus the hydrogens are in similar environments. The 
13C NMR spectrum showed a quaternary peak at 195.4 ppm which was due to the 
carbonyl carbon. The three quaternary signals at 157.2 ppm, 153.5 ppm and         
152.8 ppm corresponded to the carbons bonded to the benzyloxy and two methoxy 
groups respectively. Two peaks at 56.5 ppm and 55.9 ppm were characteristic of 
methoxy groups while the peak at 70.1 ppm was due to the methylene group. The IR 
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spectrum showed a peak at 1738 cm-1 that was indicative of carbonyl stretching 
vibrations. The mass spectrum showed an ion of 348.1346 which correlated with the 
calculated mass, 348.1362 of the desired ketone (200). The product was confirmed as 
(2-(benzyloxy)phenyl)(2,5-dimethoxyphenyl)methanone (200). 
 
The next step was the removal of the benzyl protection group using hydrogenolysis. 
The benzyloxymethanone (200) was treated with 5% palladium on carbon at 5 
atmospheres in the presence of hydrogen gas for 24 hours and furnished the required 
product (201) in good yield as shown in Scheme 57. 
 
 
Scheme 57: (i) 5% Pd/C, 5 atm, H2(g), rt, 24 h, 90%. 
 
The 1H NMR spectrum showed two singlets at 3.60 ppm and 3.67 ppm that integrated 
for 3 protons each. These singlets corresponded to the two methoxy groups at the      
2- and 5-positions of (201). The absence of the singlet at around 5.00 ppm and the 
appearance of the singlet that integrated for 1 proton at 12.04 ppm suggested that the 
benzyl substituent was no longer present. As before the peak appeared downfield and 
as a sharp signal because of internal hydrogen bonding between the hydroxy group at 
the 2'-position and the carbonyl group attached at the 1'-position of (201). The singlet 
at 6.85 ppm corresponded to the hydrogen at the 6-position of (201). There was a 
doublet of doublets at 7.26 ppm which was due to the hydrogen at the 6'-position of 
ortho-coupling with the hydrogen in the 5'-position that was verified with the 
coupling constant of 8.0Hz and meta-coupling with the hydrogen in the 4'-position 
that was verified with a coupling constant of 1.5Hz. The 13C NMR spectrum showed 
two signals at 55.2 ppm and 54.8 ppm which were characteristic of methoxy carbons. 
A quaternary signal at 200.7 ppm correlated to that of the carbonyl carbon. The 
disappearance of the peak at around 70 ppm, which was due to a methylene carbon, 
suggested that the benzyl group was removed. The quaternary signal at 161.8 ppm 
corresponded to a carbon bonded to an alcohol. The IR spectrum showed a broad 
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band at 2970 cm-1 which was characteristic of a hydroxyl group as well as a sharp 
strong signal at 1738 cm-1 which was indicative of carbonyl bond stretching 
vibrations. The mass spectrum showed an ion of 258.0883 which correlated with the 
calculated mass, 258.0892 of (201). The product was confirmed as (2,5-
dimethoxyphenyl)(2-hydroxyphenyl)methanone (201). 
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Figure 18: ORTEP diagram for the crystal structure of the (2,5-dimethoxyphenyl)(2-
hydroxyphenyl)methanone (201). 
 
The crystal structure clearly showed the internal hydrogen bonding between the 
hydroxyl group and the carbonyl group (Figure 18). The crystal structure of (201) 
also showed the possibility of free rotation around the C4- and C5-positions and the 
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C6- and C5-positions which was vital if we were to expect the formation of products 
like the unexpected xanthone (193) (Scheme 58). 
 
 
Scheme 58 
 
Finally the hydroxybenzophenone (201) was oxidized with ceric ammonium nitrate. 
The reaction was monitored over 30 minutes. After 15 minutes the starting material 
had mostly been consumed. The reaction was left for a further 15 minutes and another 
spot appeared on the TLC plate furnishing two products. The reaction was left 
overnight and furnished two surprising products after purification of the reaction 
mixture (Scheme 59). The first and major product was the unexpected                        
2-methoxyxanthone (202) while the second and minor product was the expected dione 
(203). 
 
 
Scheme 59: (i) CAN, acetonitrile, rt, 1.5 h, (202) 74%, (203) 15%. 
 
The 1H NMR spectrum for the major product showed a singlet at 3.83 ppm which 
integrated for 3 protons was due to the methoxy group in the 2-position of (202). The 
usual chemical shift for the methoxy group suggested that the methoxy group was not 
part of a hemiacetal. There was a doublet of doublets at 8.25 ppm that corresponded 
to the hydrogen at the 8-position of (202). The hydrogen displayed ortho-coupling 
with the hydrogen at the 7-position which was verified with a coupling constant of   
8.0 Hz and meta-coupling with the hydrogen at the 6-position which was verified with 
a coupling constant of 1.6 Hz. There was a singlet at 7.28 ppm which corresponded to 
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the proton in the 1-position of (202).  The 13C NMR spectrum showed a quaternary 
signal at 176.0 ppm that was characteristic of a carbonyl carbon. The two quaternary 
signals at 155.0 ppm and 154.9 ppm were due to a carbon single bonded to oxygen 
and suggested the formation of the ether linkage. A quaternary peak at 150.0 ppm was 
indicative of a carbon bonded to a methoxy group. The peak at 54.9 ppm was due to 
the methoxy group. The absence of a quaternary signal at around 90 ppm suggested 
that the acetal had not formed as was previously seen. The IR spectrum showed a 
sharp peak at 1738 ppm that was characteristic of carbonyl bond stretching vibrations. 
The mass spectrum showed an ion of 226.06120 which correlated with the calculated 
mass, 226.0630 of 2-methoxy-9H-xanthen-9-one (202) 
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Figure 19: ORTEP diagram for the crystal structure of the 2-methoxy-9H-xanthen-9-
one (202) 
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A crystal structure was obtained and the product was confirmed as 2-methoxy-9H-
xanthen-9-one (202) (Figure 19). The crystal structure clearly showed the carbonyl 
bridge and ether linkage of the xanthone flanked by the two aromatic rings. 
 
The 1H NMR spectrum for the minor product (203) showed a singlet that integrated 
for 3 protons at 3.25 ppm that was characteristic of a methoxy group in the              
4a-position. The unusual chemical shift of 3.25 ppm which was upfield of the 3.83 
ppm reported for the major product suggested an acetal had been formed. A singlet at 
6.81 ppm that integrated for 1 proton was the hydrogen in the 1-position of (203) 
which was sandwiched between the two carbonyl groups at the 2- and 9-positions. 
The two triplets were due to the hydrogens on the 6- and 7-positions of (203). The   
13C NMR spectrum showed two quaternary peaks at 185.0 ppm and 180.9 ppm that 
corresponded to carbonyl carbons. The absence of one quaternary signal at around 
155 ppm and the appearance of a quaternary signal at 95.1 ppm suggested that an 
acetal was formed as had been seen previously. The peak at 51.3 ppm was indicative 
of a methoxy group. The IR spectrum showed a strong sharp signal at 1738 cm-1 that 
was due to carbonyl bond stretching vibrations. The mass spectrum showed an ion of 
242.0568 which correlated with the calculated mass, 242.0892 of dione (203). The 
product was confirmed to be 4a-methoxy-2H-xanthene-2,9(4aH)-dione (203). 
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Scheme 60 
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It was thought that the xanthone (202) was the majority product because the 
compound could regain aromaticity unlike the dione. The following mechanism was 
postulated for the formation of the xanthone (Scheme 60). 
 
The hydroxybenzophenone (201) underwent the normal CAN addition reaction to 
afford (203). The intermediate (203) underwent the elimination of water and formed 
intermediate (205) and rearranged to maintain the aromaticity of the ring and 
furnished the xanthone (202). The dione (203) was formed by the other postulated 
mechanism mentioned earlier with the elimination of water and then methanol 
(Scheme 61). 
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Scheme 61 
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CONCLUSION 
 
Our main aim was to explore the flexibility and efficiency of the synthetic route used 
by de Koning et al.4 in the total synthesis of the naturally occurring xanthone 
bikaverin (2).  
 
The proposed synthetic route mentioned in the aims section of this dissertation was 
accomplished to a certain extent. Salicylic acid (144) was successfully protected with 
benzyl groups to furnish benzyl 2-(benzyloxy)benzoate (147) in an excellent yield of 
87%. Benzyl 2-(benzyloxy)benzoate (147) was selectively deprotected by base 
catalysed ester hydrolysis with potassium hydroxide in a methanolic solution and 
afforded 2-(benzyloxy)benzoic acid (155) in good yields of 86%. 1,4-Naphthoquinone 
(148)  was protected by first reducing to 1,4-hydroxynaphthalene (150) and then 
protecting the phenolic groups using dimethyl sulfate furnishing 1,4-
dimethoxynaphthalene (153) in a good yield of 85%. The Friedel Crafts type reaction 
with the 1,4-dimethoxynaphthalene (153) and 2-(benzyloxy)benzoic acid (155) had 
limited success. The trifluoroacetic anhydride (160) reacted with the 2-
(benzyloxy)benzoic acid (155) and formed the mixed anhydride that immediately 
reacted with the 1,4-dimethoxynaphthalene (153) and produced (2-
(benzyloxy)phenyl)(1,4-dimethoxynaphthalen-2-yl)methanone (135) in a poor 
maximum yield of 30%. The (2-(benzyloxy)phenyl)(1,4-dimethoxynaphthalen-2-
yl)methanone (135) was successfully deprotected with palladium on carbon under a 
hydrogen atmosphere using a hydrogenolysis reaction to remove the remaining benzyl 
group giving (1,4-dimethoxynaphthalen-2-yl)(2-hydroxyphenyl)methanone (136) in 
an excellent yield of 97%. The reaction with the DDQ to form the spiro-compound 
(147) was unsuccessful. The reaction only furnished starting material no matter how 
the conditions were varied. 
 
71 
 
OH
O
OH OBn
O
OBn
OH
O
OBn
O
O
O
O
(148) (153)
(144) (147) (155)
O
O
O
BnO
(135)
O
HO
O
O
(136)
O
O
OO
(137)  
Scheme 62 
 
This was when the synthesis deviated from the original aim. The first deviation came 
whereby the TFAA Friedel Crafts reaction was replaced with a higher yielding 
organometallic addition reaction. Due to the reaction being so early in the synthesis, 
more material was required to successfully test the outcomes of the following 
reactions in the sequence. The 1,4-dimethoxynaphthalene (153) was brominated via 
an electrophilic substitution using NBS under mild condition and gave the product 2-
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bromo-1,4-dimethoxynaphthalene (171) in excellent yields of 90%. The 2-bromo-1,4-
dimethoxynaphthalene (171) was lithiated at the 2-position using butyl lithium and 
added to the benzyl-2-(benzyloxy)benzoate (147)  and furnished the (2-
(benzyloxy)phenyl)(1,4-dimethoxynaphthalen-2-yl)methanone (135)  in good yields 
of 89% (Scheme 63). 
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The Friedel Crafts reaction with TFAA was a pivotal reaction in the synthesis of 
bikaverin due to the formation of the carbonyl bridge which was an important 
structural feature of the xanthone nucleus. The one pot synthesis proved to have 
limited success but further investigation is necessary to improve this step. For 
example Basavaiah et al.93 used this reaction in their synthesis of alonimid derivatives 
(208) by first forming the mixed anhydride. 
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Figure 20: The structure of alominid (208) 
73 
 
 
The reaction should be tried by reacting the 2-(benzyloxy) benzoic acid (155) with the 
TFAA for 6 hours under reflux forming the mixed anhydride and then the 1,4-
dimethoxynaphthalene (153) could be added as was done by Basavaiah et al.93. 
 
The second deviation was due to the failure of the key reaction with DDQ. Instead of 
the use of DDQ, the decision was made to use CAN. The idea was that the CAN 
would oxidize the aromatic methyl ether to the quinone and a 1,4 addition with the 
free phenol would occur or the spiro compound would result. The (1,4-
dimethoxynaphthalen-2-yl)(2-hydroxyphenyl)methanone (136) was treated with CAN 
and furnished 12a-methoxy-12aH-benzo[c]xanthene-5,7-dione (193) in a moderately 
good yield of 76% (Scheme 64). This provided an unexpected result and a mechanism 
was postulated. Further investigation would need to be done to verify the mechanism. 
 
 
Scheme 64 
 
Due to the unexpected but very interesting development, the decision was made to 
further explore the reaction with CAN on a single ring system of benzene rather than 
naphthalene. (2,5-Dimethoxyphenyl)(2-hydroxyphenyl)methanone (201) was 
synthesized via the exact same procedure detailed above and treated with CAN and 
furnished two products 2-methoxy-9H-xanthen-9-one (202) in a 80% yield and 4a-
methoxy-4aH-xanthene-2,9-dione (203) in 17% yield (Scheme 65).  
 
 
Scheme 65 
74 
 
These results proved that the reaction was reproducible to a certain extent due to the 
expected product being the minor product. Further exploration of this process would 
need to be done on different ring systems such as 1,4-dimethoxyanthracene (209) as 
well as exploring more substituted ring systems with either electron withdrawing or 
electron donating groups and monitor the effects on the reaction. 
 
 
Figure 21: The structure of 1,4 dimethoxyanthracene (209). 
 
These reactions with CAN could prove useful because the reaction could provide 
another novel route to attempt the synthesis of, for example, the complex angular 
fused xanthones cervinomycin A2 (210). 
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Figure 22: The structure of cervinomycin A2 (210). 
 
In summary, the goal of this work was to examine the flexibility of the xanthone 
synthesis proposed by de Koning et al.4 in their synthesis of bikaverin (2). This aim 
was achieved to a certain extent but more importantly a novel route to xanthones was 
discovered utilizing CAN as a key reagent in the synthesis. 
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EXPERIMENTAL 
 
GENERAL DETAILS 
 
PURIFICATION OF SOLVENTS AND REAGENTS 
All solvents used for reactions and preparative column chromatography were distilled. 
Solvents used in reactions were pre-dried in their reagent bottles and then distilled 
over the appropriate drying mediums under a nitrogen atmosphere. 
 
Tetrahydrofuran (THF) was pre-dried over sodium wire and distilled from sodium 
metal wire and benzophenone. Dichloromethane and methanol were distilled from 
calcium hydride. Triethylamine was distilled from, and stored over potassium 
hydroxide. 
EXPERIMENTAL TECHNIQUES 
Some reactions were performed under an inert atmosphere (nitrogen) using a standard 
manifold line connected to a vacuum pump. The nitrogen was dehydrated by passing 
the gas through silica gel. 
 
The Parr hydrogenator used was the Buchiglasuster Picoclave and was employed at 
the conditions outlined in the experimental procedures. 
CHROMATOGRAPHIC SEPARATION 
The Rf values quoted are for thin layer chromatography (TLC) on aluminium-backed 
Machery-Nagel ALUGRAMSil G/UV254 plates pre-coated with 0.25mm silica gel 60 
or Aldrich TLC plates, silica gel on aluminium.  
 
Machery-Nagel Silica gel 60 (particle size 0.063-0.200mm) was used as the adsorbent 
for conventional preparative column chromatography, with a silica to product ratio of 
30:1. The silica was packed into a suitable column, and the indicated solvent was 
passed through several times under pressure, until no bubbles were visible in the 
column. The crude product was adsorbed onto silica, loaded onto the silica surface 
and covered with a plug of cotton wool. The elution process was performed using the 
indicated solvent mixtures either under gravity or air pump pressure conditions. 
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SPECTROSCOPIC AND PHYSICAL DATA 
All melting points were obtained on a Reichert hot-stage microscope, and are 
uncorrected. 
 
Optical rotations were obtained on a Jasco DIP-370 Digital Polarimeter. The values 
reported each represent an average of several consistent measurements. 
 
Infrared spectra were obtained on a Bruker Vector 22 spectrometer. The absorptions 
are reported on the wavenumber (cm-1) scale, in the range 400-4000cm-1. The signals 
are reported: value (assignment). 
 
Hydrogen (1H NMR) and carbon (13C NMR) nuclear magnetic resonance spectra were 
recorded on Bruker Avance-300 at 300.13MHz respectively using standard pulse 
sequences. The probe temperature for all experiments was 300±1K. All spectra were 
recorded in deuterated chloroform (CDCl3) in 5mm NMR tubes. Chemical shifts are 
reported in parts per million (ppm) relative to tetramethylsilane as internal standard, 
in the case of 1H NMR spectra and relative to the central signal of deuterated 
chloroform taken at δ 77.00 for the 13C NMR spectra. The 1H NMR spectra chemical 
shifts are reported: value (number of hydrogens, splitting pattern, coupling constant(s) 
in Hertz were applicable, assignment). 13C NMR chemical shifts are reported value 
(assignment). 
 
Intensity data were collected on a Bruker APEX II CCD area detector diffractometer 
with graphite monochromated Mo Kα radiation (50kV, 30mA) using the APEX 2 data 
collection software. The collection method involved ω-scans of width 0.5° and 
512x512 bit data frames. Data reduction was carried out using the program SAINT+ 
(Bruker, 2005b) and face indexed absorption corrections were made using the 
program XPREP. The crystal structure was solved by direct methods using SHELXTL. 
Non-hydrogen atoms were first refined isotropically followed by anisotropic 
refinement by full matrix least-squares calculations based on F2 using SHELXTL. 
Hydrogen atoms were first located in the difference map then positioned 
geometrically and allowed to ride on their respective parent atoms.  Diagrams and 
publication material were generated using SHELXTL, PLATON94 and ORTEP-395.  
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OTHER GENERAL PROCEDURES 
Concentration of evaporation in vacuo refers to the removal of solvent under reduced 
pressure (~20mm Hg, 45oC) on a rotary evaporator and final drying on an oil pump 
(~1-2 mm Hg) at room temperature. 
 
Yields are calculated from the mass of the immediate synthetic precursor used, unless 
otherwise specified. 
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2-Hydroxybenzoic acid (5.00 g, 0.0362 moles) was dissolved in dry acetone (120 ml). 
Dry potassium carbonate (15.00 g, 0.109 moles) was added and the mixture left to stir 
at room temperature for 10 minutes. Benzyl bromide (12.9 ml, 0109 moles) was 
added to the stirring mixture and the solution was heated under reflux for 18 hour 
under nitrogen atmosphere. The cooled reaction mixture was filtered through Celite, 
which was washed with dry acetone (3 × 50 ml). The solvent was removed under 
reduced pressure and the residue dissolved in dichloromethane (25 ml). The organic 
layer was washed consecutively with 5% aqueous NaOH (25 ml), brine (20 ml) and 
distilled water (20 ml). The organic layer was dried over magnesium sulfate and the 
solvent removed under reduced pressure. The residue was purified by column 
chromatography with 5%-20% ethyl acetate/hexane as eluent to afford the product 
(147) as a white crystalline solid (10.04 g, 0.0315 moles, 87%). M.p. 47 oC - 49 oC, 
lit. M.p.80 50 oC - 51 oC; 1H NMR (CDCl3, 300 MHz) δ 7.85 (dd, J = 7.7, 1.7, 1H, Ar-
H, 6-H), 7.52 - 7.23 (m, 11H, Ar-H), 6.93 - 6.99 (m, 2H, Ar-H), 5.33 (s, 2H, CH2), 
5.13 (s, 2H, CH2); 13C NMR (CDCl3, 75 MHz) δ 166.2 (C=O)q, 158.1 (ArC-C=O)q, 
136.5 (ArC-O-CH2)q, 136.0 (ArC-C)q , 133.4 (ArCH), 131.8 (ArCH), 128.4 (2ArCH), 
128.4 (2ArCH), 128.1 (2ArCH), 128.0 (ArCH), 127.7 (ArCH), 127.0 (2ArCH), 120.6 
(ArC-C)q, 120.4 (ArCH), 113.6 (ArCH), 70.5 (CH2), 66.6 (CH2); IR νmax. 1716 
(C=O), 1598 (C=C), 1580 (C=C), 1233 (C-O), 1072 (C-O) cm-1; LRMS (m/z) 
calculated for C21H18O3 318.13, found (M+, 100%), 319.20. 
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1,4-Naphthoquinone (5.00 g, 0.0316 moles), sodium dithionite (35.86 g) in distilled 
water (300 ml) and diethyl ether (500 ml) were added to a 1 liter separatory funnel. 
The mixture was shaken every 10 minutes over an hour. The organic layer was 
separated and washed with brine (50 ml) and dried over magnesium sulfate. The 
solvent was removed under reduced pressure. The brown solid was immediately 
dissolved in dry acetone (100 ml) followed by successive additions of dry potassium 
carbonate (10.90 g, 0.0790 moles) and dimethyl sulfate (7.50 ml, 0.0790 moles). The 
stirring mixture was heated under reflux in an inert atmosphere for 18 hours. The 
cooled reaction mixture was filtered through Celite and was washed with dry acetone 
(3 × 50 ml). The solvent was removed under reduced pressure and the residue 
dissolved in diethyl ether (50 ml). The organic layer was washed consecutively with 
25% ammonia (25 ml), distilled water (25 ml), 10% HCl (25 ml), brine (25 ml) and 
distilled water (25 ml) again. The organic layer was dried over magnesium sulfate and 
the solvent removed under reduced pressure. The residue was purified by column 
chromatography with 5% ethyl acetate/hexane as eluent to afford the product (153) as 
white needle crystals (5.05 g, 0.0269 moles, 85%). M.p. 85 oC - 88 oC, lit. M.p.96      
87 oC - 88 oC; 1H NMR (CDCl3, 300 MHz) δ 8.48 - 8.09 (m, 2H Ar-H), 7.68 - 7.41 
(m, 2H, Ar-H), 6.73 (s, 2H, Ar-H, 2-H, 3-H), 4.00 (s, 6H, 2OCH3); 13C NMR (CDCl3, 
75 MHz) δ 149.5 (2ArC-OCH3)q, 126..4 (2ArC=C)q, 125.9 (2ArCH), 121.8 (2ArCH), 
103.2 (2ArCH), 55.7 (2OCH3); IR νmax. 1630 (C=C), 1592 (C=C), 1231 (C-O), 1058 
(C-O) cm-1; LRMS (m/z) calculated for C12H12O2 188.08, found (M+, 100%), 189.09. 
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2-(benzyloxy)benzoic acid
1
23
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Benzyl 2-(benzyloxy)benzoate (147) (9.00 g, 0.0283 moles) was added to the 12% 
potassium hydroxide in methanol (5.00 g in 60 ml) and heated under reflux in an inert 
atmosphere for 18 hours. The reaction mixture was subsequently cooled and quenched 
with ice cold concentrated HCl (50 ml). The mixture was filtered through Celite and 
was washed with diethyl ether (3 × 50 ml). The organic layer was dried over 
magnesium sulfate and the solvent removed under reduced pressure. The residue was 
purified by column chromatography with 20% ethyl acetate/hexane as eluent to afford 
the product (155) as white cube crystals (5.55 g, 0.0243 moles, 86%). M.p.    72 oC - 
75 oC, lit. M.p.82 73.5 oC - 74.5 oC; 1H NMR (CDCl3, 300 MHz) δ 10.71 (s, 1H Ar-
OH), 8.14 (dd, J = 7.8, 1.7 1H, Ar-H, 6-H), 7.60 - 7.29 (m, 6H, Ar-H), 7.15 - 7.03 (m, 
2H, Ar-H), 5.48 (s, 2H, CH2); 13C NMR (CDCl3, 75 MHz) δ  166.2 (HOC=O)q, 157.6 
(ArC-C=O)q, 135.1 (ArCH), 134.7 (ArC-O-CH2)q, 133.6 (ArCH), 129.0 (2ArCH), 
129.0 (ArCH), 127.8 (2ArCH), 122.2 (ArCH), 118.1 (ArC-C)q, 113.3 (ArCH), 72.0 
(CH2); IR νmax. 2970 (C-OH), 1674 (C=O), 1599 (C=C), 1232 (C-O) cm-1; LRMS 
(m/z) calculated for C14H12O3 228.08, found (M+, 100%), 229.15 
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2-(Benzyloxy)benzoic acid (155) (3.64 g, 0.0160 moles) was premixed with the 
trifluoroacetic anhydride (2.25 ml, 0.0160 moles) in dry dichloromethane (10 ml) and 
was rapidly added to the 1,4-dimethoxynaphthalene (3.00 g, 0.0160 moles) dissolved 
in dry dichloromethane (10 ml). The stirring mixture was heated under reflux for 92 
hours with the addition of further trifluoroacetic anhydride (2.25 ml, 0.0160 moles) at 
6 hours, 24 hours and 48 hours. The mixture was allowed to cool and was quenched 
with successive additions of methanol (50 ml) and saturated sodium hydrogen 
carbonate solution (50 ml). The organic material was extracted into dichloromethane 
(4 × 25ml) and dried over magnesium sulfate. The solvent was removed under 
reduced pressure and the residue was purified by column chromatography with 5% 
ethyl acetate/hexane as eluent to afford the product (135) as pale green plate crystals 
(1.14 g, 0.00455 moles, 30%) from methanol. M.p. 105 oC - 107 oC; 1H NMR 
(CDCl3, 300 MHz) δ 8.33 - 7.99 (m, 2H Ar-H), 7.69 (d, 1H, J = 7.5, Ar-H, 6'-H), 7.61 
- 7.42 (m, 3H, Ar-H), 7.15 – 6.96 (m, 3H, Ar-H), 6.96 - 6.84 (m, 2H, Ar-H), 6.82 (s, 
1H, Ar-H, 3-H), 6.74 (d, J = 7.6, 2H, Ar-H, 5-H, 8-H), 4.89 (s, 2H, CH2), 3.91 (s, 3H, 
OCH3), 3.59 ((s, 3H, OCH3); 13C NMR (CDCl3, 75 MHz) δ  196.3 (C=O)q, 157.5 
(ArC-OCH2)q, 151.7 (ArC-OCH3)q, 150.3 (ArC-OCH3)q, 135.9 (ArC-C=O)q, 132.9 
(ArCH), 130.7 (ArC-C=O)q, 130.2 (ArCH), 129.0 (ArC=C)q, 128.8 (ArC=C)q , 128.4 
(ArC-CH2)q, 127.9 (2ArCH), 127.5 (ArCH) , 127.2 (ArCH), 126.8 (ArCH), 126.8 
(2ArCH), 123.1 (ArCH), 122.4 (ArCH), 120.7 (ArCH), 112.3 (ArCH), 103.0 (ArCH), 
70.3 (CH2), 63.6 (OCH3), 55.8 (OCH3); IR νmax. 1734 (C=O), 1594 (C=C), 1290 (C-
O), 1096 (C-O) cm-1; HRMS (m/z) calculated for C26H22O4 398.1518, found 
398.1523. 
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N-Bromosuccinimide (3.80 g, 0.0214 moles) was added to the 1,4-
dimethoxynaphthalene (4.00 g, 0.0213 moles) in dry dichloromethane (30 ml). The 
mixture was stirred for 18 hours at room temperature. The mixture was washed with 
saturated sodium sulfite solution (25 ml) and extracted into dichloromethane (3 × 50 
ml). The organic layer was dried over magnesium sulfate. The solvent was removed 
under reduced pressure and the residue was purified by column chromatography with 
5% ethyl acetate/hexane as eluent to afford the product (171) as white grains (5.12 g, 
0.0192 moles, 90%). M.p. 56 oC - 58 oC, lit. M.p.86 54 oC - 55 oC; 1H NMR (CDCl3, 
300 MHz) δ 8.28 - 8.05 (m, 2H Ar-H), 7.63 - 7.48 (m, 2H, Ar-H), 6.91 (s, 1H, Ar-H, 
1-H), 3.97 (s, 3H, OCH3), 3.98 (s, 3H, OCH3); 13C NMR (CDCl3, 75 MHz) δ 152.1 
(ArC-OCH3)q, 146.6 (ArC-OCH3)q, 128..9 (ArC=C)q, 127.3 (ArCH), 125.5 (ArCH), 
125.5 (ArC=C)q 122.2 (ArCH), 121.7 (ArCH), 111.8 (ArCBr), 107.8 (ArCH), 61.3 
(OCH3), 55.7 (OCH3); IR νmax. 1615 (C=C), 1575 (C=C), 1105 (C-O), 773 (C-Br) cm-
1; LRMS (m/z) calculated for C12H11BrO2, 265.99, found (M+, 100%), 267.03 
 
 
 
2-Bromo-1,4-dimethoxynaphthalene (171) (4.00 g, 0.0148 moles) was dissolved in 
dry tetrahydrofuran (20 ml) and stirred at –78 oC for 5 minutes under an inert 
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atmosphere. The N-butyl lithium (1.2M, 0.0150moles, 18ml) was added dropwise at   
–78 oC and the mixture stirred at 78oC for 45 minutes in an inert atmosphere. The 
lithiated mixture was added dropwise to the benzyl 2-(benzyloxy)benzoate (147) 
(4.78 g, 0.0143 moles) in dry tetrahydrofuran (20 ml) at –78 oC. The mixture was 
stirred for an additional 30 minutes at –78 oC in an inert atmosphere. The mixture was 
quenched with a saturated solution of ammonium chloride (25 ml) at –78 oC and 
allowed to reach room temperature. The tetrahydrofuran was removed under reduced 
pressure and ethyl acetate (50 ml) was added. The organic layer was washed 
consecutively with water (25 ml) and brine (25 ml) and dried over magnesium sulfate. 
The solvent was removed under reduced pressure and the residue was purified by 
column chromatography with 5% - 20% ethyl acetate/hexane as eluent to afford the 
product (135) as pale green plate crystals (5.07 g, 0.0127 moles, 89%) in methanol. 
M.p. 105 oC - 107 oC; 1H NMR (CDCl3, 300 MHz) δ 8.33 - 7.99 (m, 2H Ar-H), 7.69 
(d, 1H, J = 7.5, Ar-H, 6'-H), 7.61 - 7.42 (m, 3H, Ar-H), 7.15 – 6.96 (m, 3H, Ar-H), 
6.96 - 6.84 (m, 2H, Ar-H), 6.82 (s, 1H, Ar-H, 3-H), 6.74 (d, J = 7.6, 2H, Ar-H, 5-H, 
8-H), 4.89 (s, 2H, CH2), 3.91 (s, 3H, OCH3), 3.59 ((s, 3H, OCH3); 13C NMR (CDCl3, 
75 MHz) δ  196.3 (C=O)q, 157.5 (ArC-OCH2)q, 151.7 (ArC-OCH3)q, 150.3 (ArC-
OCH3)q, 135.9 (ArC-C=O)q, 132.9 (ArCH), 130.7 (ArC-C=O)q, 130.2 (ArCH), 129.0 
(ArC=C)q, 128.8 (ArC=C)q , 128.4 (ArC-CH2)q, 127.9 (2ArCH), 127.5 (ArCH) , 
127.2 (ArCH), 126.8 (ArCH), 126.8 (2ArCH), 123.1 (ArCH), 122.4 (ArCH), 120.7 
(ArCH), 112.3 (ArCH), 103.0 (ArCH), 70.3 (CH2), 63.6 (OCH3), 55.8 (OCH3); IR 
νmax. 1734 (C=O), 1594 (C=C), 1290 (C-O), 1096 (C-O) cm-1; HRMS (m/z) 
calculated for C26H22O4, 398.1518, found 398.1523. 
 
OO
O
HO
(136)
(1,4-dimethoxynaphthalen-2-yl)(2-hydroxyphenyl)methanone
1 2
4
1'
2'
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5% Palladium on carbon (0.25 g) was added to (2-(benzyloxy)phenyl)(1,4-
dimethoxynaphthalen-2-yl)methanone (135) (2.50 g, 0.00627 moles) in dry methanol 
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(30 ml). The mixture was submitted to a hydrogen atmosphere at a pressure of 4.5 
bars for 24 hours. The mixture was filtered through Celite and washed with 
dichloromethane (3 × 50 ml). The organic layer was dried over magnesium sulphate. 
The solvent was removed under reduced pressure and the residue was purified by 
column chromatography with 10% ethyl acetate/hexane as eluent to afford the product 
(136) as pale green needles (1.88 g, 0.00608 moles, 97%) in methanol. M.p. 116 oC - 
118 oC; 1H NMR (CDCl3, 300 MHz) δ 12.25 (s, 1H, Ar-OH) 8.31 - 8.13 (m, 2H Ar-
H), 7.69 - 7.39 (m, 4H, Ar-H), 7.05 (d, J = 8.7, 1H, Ar-H, 6'-H), 6.78 (t, J = 7.6 1H, 
Ar-H, 5'-H), 6.68 (s, 1H, Ar-H, 3-H), 3.94 (s, 3H, OCH3), 3.81 ((s, 3H, OCH3); 13C 
NMR (CDCl3, 75 MHz) δ  202.4 (C=O)q, 163.1 (ArC-OH)q, 151.8 (ArC-OCH3)q, 
147.5 (ArC-OCH3)q, 136.9 (ArCH), 134.2 (ArCH), 128.5 (ArC-C=O)q, 127.7 (ArC-
C=O)q, 127.4 (ArCH), 127.2 (ArCH), 126.4 (ArC=C)q, 122.7 (ArCH), 122.6 (ArCH), 
120.0 (ArC=C)q, 119.1 (ArCH), 118.1 (ArCH), 102.3 (ArCH), 63.7 (OCH3), 55.8 
(OCH3); IR νmax. 2970 (C-OH), 1739 (C=O), 1592 (C=C), 1216 (C-O) cm-1; HRMS 
(m/z) calculated for C19H16O4, 308,1049, found 308.1048. 
  
 
 
Ceric ammonium nitrate (13.3 g, 0.0243 moles) in water (25 ml) was added dropwise 
to a stirring mixture of (1,4-dimethoxynaphthalene-2-yl)(2-hydroxyphenyl)methanone 
(136) (1.50 g, 0.00486 moles) in acetonitrile (25 ml) and chloroform (5 ml). The 
mixture was stirred at room temperature for 90 minutes. The reaction mixture was 
filtered through Celite and washed with ethyl acetate (3 × 25 ml). The organic layer 
was washed consecutively with saturated sodium hydrogen carbonate solution (25 
ml), brine (25 ml) and water (25 ml). The organic layer was dried over magnesium 
sulphate. The solvent was removed under reduced pressure and the residue was 
purified by column chromatography with 5% ethyl acetate/hexane as eluent to afford 
the product (193) as orange rod crystals (1.02 g, 0.00348 moles, 72%) in ethyl acetate. 
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M.p. 111 oC - 113 oC; [α] = -7.2;  1H NMR (CDCl3, 300 MHz) δ  8.16 (d, J = 7.8, 1H, 
Ar-H, 8-H), 8.07 - 8.02 (m, 2H, Ar-H), 7.83 - 7.57 (m, 3H, Ar-H), 7.26 (s, 1H, Ar-H, 
6-H), 7.24 - 7.08 (m, 2H, Ar-H), 3.03 (s, 3H, OCH3); 13C NMR (CDCl3, 75 MHz) δ  
184.0 (C=O)q, 181.0 (C=O)q, 157.8 (ArC-OCAr)q, 143.8 (ArC-C=O)q, 137.0 (ArCH), 
136.6 (ArC-C=O)q, 133.9 (ArCH), 130.8 (ArC=C)q, 130.6 (ArCH), 130.2 (ArCH), 
127.6 (ArCH), 126.9 (ArCH), 126.5 (ArCH), 123.2 (ArCH), 121.5 (ArC=C)q, 118.6 
(ArCH), 96.4 (ArCO-C-OCH3), 51.5 (OCH3); IR νmax. 1738 (C=O), 1637 (C=C), 
1605 (C=C), 1226 (C-O), 1129 (C-O), 1099 (C-O) cm-1; HRMS (m/z) calculated for 
C18H12O4, 292.0736, found 308.1048, found 276.0778 (100%). 
 
O
O
(197)
2-bromo-1,4-dimethoxybenzene
Br1 2
34
 
 
N-Bromosuccinimide (6.65 g, 0.0373 moles) was added to the 1,4-dimethoxybenzene 
(5.02 g, 0.0363 moles) in dry dichloromethane (30 ml). The stirring mixture was 
heated under reflux for 48 hours. The mixture was allowed to cool to room 
temperature and was washed with saturated sodium sulfite solution (25 ml). The 
mixture was extracted into dichloromethane (3 × 50 ml). The organic layer was dried 
over magnesium sulfate. The solvent was removed under reduced pressure and the 
residue was purified by column chromatography with 5% ethyl acetate/hexane as 
eluent to afford the product (197) as a colorless oil (7.01 g, 0.0323 moles, 89%). 1H 
NMR (CDCl3, 300 MHz) δ 7.11 (s, 1H Ar-H, 1-H), 6.91 - 6.74 (m, 2H, Ar-H), 3.82 
(s, 3H, OCH3), 3.74 (s, 3H, OCH3); 13C NMR (CDCl3, 75 MHz) δ 154.0 (ArC-
OCH3)q, 150.3 (ArC-OCH3)q, 119.0 (ArCH), 113.6 (ArCBr)q, 112.9 (ArCH), 111.9 
(ArCH), 56.8 (OCH3), 55.9 (OCH3); IR νmax. 1607 (C=C), 1575 (C=C), 1036 (C-O), 
730 (C-Br) cm-1; LRMS (m/z) calculated for C8H9BrO2, 225.98, found (M+, 100%), 
227.05. 
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2-Bromo-1,4-dimethoxy benzene (2.50 g, 0.0115 moles) was dissolved in dry 
tetrahydrofuran (15 ml) and stirred at –78 oC for 5 minutes in an inert atmosphere. N-
Butyl lithium (1.2 M, 0.0115 moles, 14 ml) was added dropwise at –78 oC and the 
mixture stirred at –78 oC for 45 minutes in an inert atmosphere. The lithiated mixture 
was added dropwise to the benzyl 2-(benzyloxy)benzoate (147) (3.67 g,             
0.0115 moles) in dry tetrahydrofuran (20 ml) at –78 oC over 30 minutes. The mixture 
was stirred for an additional 30 minutes at –78oC in an inert atmosphere and thereafter 
was quenched with a saturated solution of ammonium chloride (25 ml) at –78 oC and 
allowed to reach room temperature. The tetrahydrofuran was removed under reduced 
pressure and ethyl acetate (50 ml) was added to dissolve the residue and was washed 
consecutively with water (25 ml) and brine (25 ml) and dried over magnesium sulfate. 
The solvent was removed under reduced pressure and the residue was purified by 
column chromatography with 5% - 20% ethyl acetate/hexane as eluent to afford the 
product (200) as a light yellow oil (2.85 g, 0.00819 moles, 72%). 1H NMR (CDCl3, 
300 MHz) δ 7.59 (dd, J = 7.6, 1.7 1H Ar-H, 6'-H), 7.48 - 7.32 (m, 2H, Ar-H), 7.22 - 
7.15 (m, 2H, Ar-H), 7.12 - 7.6.88 (m, 6H, Ar-H), 6.76 (d, J = 7.4 , 1H, Ar-H, 3-H) 
4.94 (s, 2H, CH2), 3.75 (s, 3H, OCH3), 3.52 (s, 3H, OCH3); 13C NMR (CDCl3, 75 
MHz) δ  195.4 (C=O)q, 157.2 (ArC-OCH2)q, 153.5 (ArC-OCH3)q, 152.8 (ArC-
OCH3)q, 136.4 (ArC-C=O)q, 132.6 (ArCH), 130.8 (ArC-C=O)q, 130.4 (ArC=C)q 
130.2 (ArCH), 129.0 (ArC=C)q, 128.8 (ArC=C)q , 128.4 (ArC-CH2)q, 128.2 (ArCH) , 
127.5 (2ArCH), 127.0 (ArCH), 126.7 (2ArCH), 120.8 (ArCH), 118.5 (ArCH), 114.5 
(ArCH), 113.4 (ArCH), 112.3 (ArCH), 70.1 (CH2), 56.5 (OCH3), 55.9 (OCH3); IR 
νmax. 1738 (C=O), 1644 (C=C), 1595 (C=C), 1217 (C-O), 1042 (C-O) cm-1; HRMS 
(m/z) calculated for C22H20O4, 348.1362, found 348.1346. 
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5% Palladium on carbon (0.05 g) was added to (2-(benzyloxy)phenyl)(2,5-
dimethoxyphenyl)methanone (200) (1.00 g, 0.00287 moles) in dry methanol (30 ml). 
The mixture was submitted to a hydrogen atmosphere at a pressure of 4.5 bars for 24 
hours. The mixture was filtered through Celite and washed with dichloromethane (3 × 
50 ml). The organic layer was dried over magnesium sulphate. The solvent was 
removed reduced pressure and the residue was purified by column chromatography 
with 10% ethyl acetate/hexane as eluent to afford the product (200) as white needles 
(0.66 g, 0.00258 moles) in methanol. M.p. 95 oC - 98 oC, lit. M.p.97 98 oC - 100 oC   
1H NMR (CDCl3, 300 MHz) δ 12.04 (s, 1H, Ar-OH) 7.41 - 7.31 (m, 1H Ar-H), 7.26 
(dd, J = 8.0, 1.5, 1H, Ar-H, 5'-H), 6.96 – 6.87 (m, 2H, Ar-H), 6.85 (s, 1H, Ar-H, 6-H), 
6.78 - 6.55 (m, 2H, Ar-H), 3.67 (s, 3H, OCH3), 3.60 ((s, 3H, OCH3); 13C NMR 
(CDCl3, 75 MHz) δ  200.7 (C=O)q, 161.8 (ArC-OH)q, 152.4 (ArC-OCH3)q, 149.5 
(ArC-OCH3)q, 135.5 (ArCH), 132.8 (ArCH), 127.2 (ArC-C=O)q, 119.0 (ArC-C=O)q, 
117.8 (ArCH), 117.0 (ArCH), 116.0 (ArCH), 112.9 (ArCH), 111.9 (ArCH), 55.2 
(OCH3), 54.7 (OCH3); IR νmax. 2941 (C-OH), 1738 (C=O), 1575 (C=C), 1221 (C-O) 
cm-1; HRMS (m/z) calculated for C15H14O4, 258.0892, found 258.0883  
 
 
 
Ceric ammonium nitrate (1.06 g, 0.00194 moles) in water (5 ml) was added dropwise 
to a stirring mixture of (2,5-dimethoxyphenyl)(2-hydroxyphenyl)methanone (201) 
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(0.100 g, 0.000388 moles) in acetonitrile (10 ml) and chloroform (2.5 ml). The 
mixture was stirred at room temperature for 24 hours. The reaction mixture was 
filtered through Celite and washed with ethyl acetate (3 × 25 ml). The organic layer 
was washed consecutively with saturated sodium hydrogen carbonate solution         
(25 ml), brine (25 ml) and water (25 ml) and was dried over magnesium sulfate. The 
solvent was removed under reduced pressure and the residue was purified by column 
chromatography with 5% ethyl acetate/hexane as eluent to afford the products (202) 
as white needles (0.065 g, 0.00288 moles, 74%) and (203) as orange grains (0.015 g, 
0.0000620 moles, 15%). M.p. 130 oC - 133 oC, lit. M.p.98 134 oC - 135 oC; 1H NMR 
(CDCl3, 300MHz) δ  8.25 (dd, J = 8.0, 1.6, 1H Ar-H, 8-H),  7.65 - 7.55 (m, 2H, Ar-
H), 7.42 - 7.31 (dd, J = 7.8, 1.4, 1H, Ar-H, 5-H), 7.29 (s, 1H, Ar-H, 1-H), 7.28 - 7.14 
(m, 2H, Ar-H), 3.83 (s, 3H, OCH3); 13C NMR (CDCl3, 75MHz) δ 176.0 (C=O)q, 
155.0 (ArC-OCAr)q, 154.9 (ArC-OCAr)q 149.9 (ArC-OCH3)q, 133.5 (ArCH), 125.6 
(ArCH), 123.8 (ArCH), 122.6 (ArCH), 121.0 (ArC-C=O)q, 120.2 (ArC-C=O)q, 118.4 
(ArCH), 116.9 (ArCH), 104.8 (ArCH), 54.9 (OCH3); IR νmax. 1738 (C=O), 1647 
(C=C), 1614 (C=C), 1211 (C-O), 1142 (C-O) cm-1; HRMS (m/z) calculated for 
C14H10O3, 226.0630, found 226.0620. 
 
O
O
O
O
(203)
4a-methoxy-2H-xanthene-2,9(4aH)-dione
12
3
4 5
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M.p. 92 oC - 95 oC; [α] = -6.111o;  1H NMR (CDCl3, 300 MHz) δ  7.94 (d, J = 7.8, 1H 
Ar-H, 3-H), 7.53 (t, J = 7.8, 1H, Ar-H, 7-H), 7.11 (t, J = 7.5, 1H, Ar-H, 6-H), 7.03 (d, 
J = 10.0 1H, Ar-H, 4-H), 6.81 (s, 1H, Ar-H, 1-H), 6.37 (dd, J = 10.4, 1.9, 2H, 5-H, 8-
H), 3.25 (s, 3H, OCH3); 13C NMR (CDCl3, 75 MHz) δ  185.05 (C=O)q, 180.94 
(C=O)q, 157.0 (ArC-OCAr)q, 144.5 (ArC-C=O)q, 140.1 (ArCH), 137.0 (ArCH), 130.7 
(ArCH), 128.5 (ArCH), 127.5 (ArCH), 123.3 (ArCH), 121.6 (ArC-C=O)q, 118.5  
(ArCH), 95.1 (ArCO-C-OCH3)q, 51.3 (OCH3); IR νmax. 1738 (C=O), 1645 (C=C), 
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1604 (C=C), 1217 (C-O), 1140 (C-O), 1098 (C-O) cm-1; HRMS (m/z) calculated for 
C14H10O4, 242.0479, found 242.05676 (100%). 
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APPENDIX I 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1:  Crystal data and structure refinement for (1,4-dimethoxy naphthalen-2-
yl)(2-hydroxy phenyl) methanone. 
O O
O
OH
 
 
Identification code  8m_jn1_0s 
Empirical formula  C18 H12 O4 
Formula weight  292.28 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P2(1)/n 
Unit cell dimensions a = 13.0183(7) Å  
 = 90°. 
 b = 13.0356(6) Å  
 = 98.662(3)°. 
 c = 15.9224(7) Å  
 = 90°. 
Volume 2671.2(2) Å3 
Z 8 
Density (calculated) 1.454 Mg/m3 
Absorption coefficient 0.103 mm-1 
F(000) 1216 
Crystal size 0.49 x 0.28 x 0.25 mm3 
Theta range for data collection 1.89 to 28.00°. 
Index ranges -16<=h<=17, -17<=k<=15, -19<=l<=21 
Reflections collected 19971 
Independent reflections 6440 [R(int) = 0.0773] 
Completeness to theta = 28.00° 100.0 %  
Absorption correction None 
Max. and min. transmission 0.9747 and 0.9512 
Refinement method Full-matrix least-squares on F2 
 
 
Data / restraints / parameters 6440 / 0 / 399 
Goodness-of-fit on F2 0.994 
Final R indices [I>2sigma(I)] R1 = 0.0788, wR2 = 0.1969 
R indices (all data) R1 = 0.1306, wR2 = 0.2362 
Largest diff. peak and hole 1.128 and -0.307 e.Å-3 
 
Table 1:  Crystal data and structure refinement for 12a-methoxy-5H-
benzo[c]xanthenes 5,7(12aH)-dione 
O
O
O
O
 
 
Identification code  8m_jn3_0f 
Empirical formula  C19 H16 O4 
Formula weight  308.32 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Orthorhombic 
Space group  Pbca 
Unit cell dimensions a = 17.551(2) Å  
 = 90°. 
 b = 8.1552(12) Å  
 = 90°. 
 c = 21.281(3) Å  
 = 90°. 
Volume 3046.0(7) Å3 
Z 8 
Density (calculated) 1.345 Mg/m3 
Absorption coefficient 0.094 mm-1 
F(000) 1296 
Crystal size 0.49 x 0.14 x 0.05 mm3 
Theta range for data collection 1.91 to 25.00°. 
Index ranges -20<=h<=19, -9<=k<=8, -15<=l<=25 
 
 
Reflections collected 12601 
Independent reflections 2658 [R(int) = 0.1074] 
Completeness to theta = 25.00° 99.1 %  
Absorption correction None 
Max. and min. transmission 0.9953 and 0.9553 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2658 / 0 / 211 
Goodness-of-fit on F2 1.303 
Final R indices [I>2sigma(I)] R1 = 0.0981, wR2 = 0.1418 
R indices (all data) R1 = 0.1732, wR2 = 0.1587 
Largest diff. peak and hole 0.333 and -0.303 e.Å-3 
 
Table 1:  Crystal data and structure refinement for (2,5-dimethoxy phenyl)(2-hydroxy 
phenyl) methanone 
O O
O
OH
 
 
Identification code  8m_jn4_0s 
Empirical formula  C15 H14 O4 
Formula weight  258.26 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group  P-1 
Unit cell dimensions a = 7.4530(2) Å  
 = 80.0310(10)°. 
 b = 9.0877(2) Å  
 = 79.7850(10)°. 
 c = 9.9834(3) Å  
  = 74.4330(10)°. 
Volume 635.41(3) Å
3
 
 
 
Z 2 
Density (calculated) 1.350 Mg/m
3
 
Absorption coefficient 0.098 mm
-1
 
F(000) 272 
Crystal size 0.40 x 0.34 x 0.14 mm
3
 
Theta range for data collection 2.09 to 28.00°. 
Index ranges -9<=h<=9, -11<=k<=11, -13<=l<=13 
Reflections collected 13834 
Independent reflections 3065 [R(int) = 0.0414] 
Completeness to theta = 28.00° 100.0 %  
Absorption correction None 
Max. and min. transmission 0.9864 and 0.9619 
Refinement method Full-matrix least-squares on F
2
 
Data / restraints / parameters 3065 / 0 / 175 
Goodness-of-fit on F2 1.085 
Final R indices [I>2sigma(I)] R1 = 0.0369, wR2 = 0.0983 
R indices (all data) R1 = 0.0456, wR2 = 0.1031 
Largest diff. peak and hole 0.283 and -0.208 e.Å
-3
 
 
Table 1:  Crystal data and structure refinement for 2-methoxy-9H-xanthen-9-one 
 
 
Identification code  8m_jn5_0f 
Empirical formula  C14 H10 O3 
Formula weight  226.22 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P2(1)/n 
 
 
 
 
Unit cell dimensions a = 4.7765(2) Å  
 = 90°. 
 b = 14.2280(5) Å  
 = 93.426(2)°. 
 c = 15.4365(6) Å  
  = 90°. 
Volume 1047.19(7) Å
3
 
Z 4 
Density (calculated) 1.435 Mg/m
3
 
Absorption coefficient 0.101 mm
-1
 
F(000) 472 
Crystal size 0.60 x 0.07 x 0.06 mm
3
 
Theta range for data collection 1.95 to 28.00°. 
Index ranges -6<=h<=6, -18<=k<=18, -20<=l<=20 
Reflections collected 15813 
Independent reflections 2533 [R(int) = 0.0446] 
Completeness to theta = 28.00° 100.0 %  
Absorption correction None 
Max. and min. transmission 0.9940 and 0.9418 
Refinement method Full-matrix least-squares on F
2
 
Data / restraints / parameters 2533 / 0 / 155 
Goodness-of-fit on F2 1.026 
Final R indices [I>2sigma(I)] R1 = 0.0466, wR2 = 0.1072 
R indices (all data) R1 = 0.0695, wR2 = 0.1178 
Largest diff. peak and hole 0.288 and -0.273 e.Å
-3
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MSC0408_HR_20090320-c1 #27 RT: 1.57 AV: 1 NL: 2.13E6
T: + c EI Full ms [ 379.50-406.50]
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MSC0708_HR_20090320-c1 #62 RT: 4.06 AV: 1 NL: 2.11E6
T: + c EI Full ms [ 291.50-320.50]
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